George J. Chang, MD, MS, MHCM, FACS, FASCO, FASCRS, FSSO

Peer-Reviewed Articles

1. Herb JN, Hu CY, Giordano SH, Chang GJ, Snyder RA. Association of social determinants of health diagnosis codes with overall survival in Medicare-insured patients with cancer. J Natl Cancer Inst, 2026. e-Pub 2026. PMID: 41849418.
2. Benson AB, Venook AP, Adam M, Ambelil M, Chang GJ, Chen YJ, Ciombor KK, Cohen SA, Conces M, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Harmath C, Haste P, Hecht JR, Hoffe S, Hicks JK, Hunt S, Hussan H, Johung KL, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Mannan R, Maratt JK, Messersmith WA, Meyer J, Meyerhardt J, Miller ED, Mulcahy M, Nurkin S, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Singer L, Sofocleous CT, Tavakkoli A, Willett CG, Wu C, Baez-Cruz F, Gurski L, Jones F. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon Cancer v5.2025. Accessed 10/30/25. NCCN Guidelines for Colon Cancer, 2026. e-Pub 2026.
3. Benson AB, Venook AP, Cohen SA, Adam M, Ambelil M, Chang GJ, Ciombor KK, Conces M, Deming D, Garrido-Laguna I, Grem JL, Harmath C, Haste P, Hecht JR, Hoffe S, Hicks JK, Hunt S, Hussan H, Johung KL, Joseph N, Kirilcuk N, Malla M, Mannan R, Maratt JK, Messersmith WA, Meyer J, Meyerhardt J, Miller ED, Mulcahy M, Nurkin S, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Singer L, Sofocleous CT, Tavakkoli A, Willett CG, Wu C, Baez-Cruz F, Gurski L, Jones F. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Appendiceal Neoplasms and Cancers v1.2026. Accessed 10/30/25. NCCN Guidelines for Appendiceal Neoplasms and Cancers, 2026. e-Pub 2026.
4. Herb JN, Hu CY, Manisundaram NV, Chang GJ, Snyder RA. Association of cancer with racial disparities in financial health: a national cohort study. Support Care Cancer 33(9):828, 2025. e-Pub 2025. PMID: 40888994.
5. Manisundaram NV, Hu CY, Herb JN, DiBrito SR, Snyder RA, Uppal A, Chang GJ. Disparities in Survival Across Multiple Cancer Sites at Low-Income-Serving Hospitals. Ann Surg Oncol 32(9):6807-6816, 2025. e-Pub 2025. PMID: 40450170.
6. Sica, GS, Anania, G, Fiorani, C, Siragusa, L, Vinci, D, Caricato, M, Delrio, P, Agrusa, A, Baldazzi, G, Reddavid, R, Pellino, G, Garcia-Granero, A, Ferraro, L, Lygre, KB, Balaban, V, Sugoor, PT, Tzovaras, G, Chen, WT, Min, BS, Tan, MN, Sammour, T, Takashi, A, Benz, S, Ozben, V, Pedrazzani, C, Formisano, G, Kim, SH, Akyol, C, West, NP, Guida, AM, Divizia, A, Giani, A, Banipal, GS, Al-Najami, I, Luo, W, Bellato, V, Pirozzi, BM, Seow-En, I, Bernhoff, R, Dimofte, G, Musina, AM, Konishi, T, Lee, YS, Morarasu, S, Gouvas, N, Zurleni, T, Carnevali, P, Fukunaga, Y, Pramateftakis, M, Balciscueta, Z, Chaouch, MA, Chang, GJ, Carlo, SD, Hamzaoglu, I, Buono, GD, Petrov, A, Mathis, KL, Kazaryan, AM, Mazzola, M, Buscemi, S, Jovine, E, Scabini, S, Bertani, E, Ferrari, G, Khan, J, Pfeffer, F, Spinoglio, G, Luglio, G, Navarra, G, Kobayashi, H, Merkel, S, Cassini, D, Piozzi, GN, Spalluto, M. Standardization of the surgical technique and reporting for radical right colectomy with central vascular ligation and complete mesocolic excision (RRoC-STAR). BJS open 9(3), 2025. e-Pub 2025. PMID: 40503608.
7. Bhutiani, N, Ochiai, K, Peacock, O, You, YN, Bednarski, BK, Messick, C, Skibber, JM, White, MG, Chang, GJ, Konishi, T, Uppal, A. ASO Visual Abstract. Annals of surgical oncology 32(6):4257-4258, 2025. e-Pub 2025. PMID: 40202570.
8. Sica, GS, Anania, G, Fiorani, C, Siragusa, L, Vinci, D, Caricato, M, Delrio, P, Agrusa, A, Baldazzi, G, Reddavid, R, Pellino, G, Garcia-Granero, A, Ferraro, L, Lygre, KB, Balaban, V, Sugoor, PT, Tzovaras, G, Chen, WT, Min, BS, Tan, MN, Sammour, T, Takashi, A, Benz, S, Ozben, V, Pedrazzani, C, Formisano, G, Kim, SH, Akyol, C, West, NP, Guida, AM, Divizia, A, Giani, A, Banipal, GS, Al-Najami, I, Luo, W, Bellato, V, Pirozzi, BM, Seow-En, I, Bernhoff, R, Dimofte, G, Musina, AM, Konishi, T, Lee, YS, Morarasu, S, Gouvas, N, Zurleni, T, Carnevali, P, Fukunaga, Y, Pramateftakis, M, Balciscueta, Z, Chaouch, MA, Chang, GJ, Carlo, SD, Hamzaoglu, I, Buono, GD, Petrov, A, Mathis, KL, Kazaryan, AM, Mazzola, M, Buscemi, S, Jovine, E, Scabini, S, Bertani, E, Ferrari, G, Khan, J, Pfeffer, F, Spinoglio, G, Luglio, G, Navarra, G, Kobayashi, H, Merkel, S, Cassini, D, Piozzi, GN, Spalluto, M. Standardization of the surgical technique and reporting for radical right colectomy with central vascular ligation and complete mesocolic excision (RRoC-STAR). BJS open 9(3), 2025. e-Pub 2025. PMID: 40503608.
9. Manisundaram, N, Snyder, RA, Hu, C, DiBrito, SR, Herb, JN, Chang, GJ. Impact of Medicaid expansion on racial disparities among patients with gastrointestinal cancer. Cancer 131(9), 2025. e-Pub 2025. PMID: 40267029.
10. White, MG, Ayabe, RI, Zeineddine, MA, Zeineddine, F, Yousef, A, Yousef, M, Galbraith, NJ, Iorgulescu, JB, Scally, CP, Fournier, KF, Newhook, TE, You, YN, Willis, JA, Kopetz, S, Chang, GJ, Shen, JY, Uppal, A. Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis. Translational Oncology 55, 2025. e-Pub 2025. PMID: 40184716.
11. Bhutiani N, Ochiai K, Peacock O, You YN, Bednarski BK, Messick C, Skibber JM, White MG, Chang GJ, Konishi T, Uppal A. Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer. Ann Surg Oncol 32(5):3098-3105, 2025. e-Pub 2025. PMID: 39924589.
12. Manisundaram N, Childers CP, Hu CY, Uppal A, Konishi T, Bednarski BK, White MG, Peacock O, You YN, Chang GJ. Rise in Minimally Invasive Surgery for Colorectal Cancer Is Associated With Adoption of Robotic Surgery. Dis Colon Rectum 68(4):426-436, 2025. e-Pub 2025. PMID: 39745312.
13. Ogomori K, Broering J, Rogine C, Kin C, Chang GJ, Finlayson E. Evaluating a digital prehabilitation tool in patients with colorectal surgery: protocol for a multisite randomised controlled trial. BMJ Open 15(2), 2025. e-Pub 2025. PMID: 39965940.
14. Bhutiani N, Hu CY, Palis B, Cotler J, Shi Q, Washington MK, Goldberg RM, Steele SR, Chang GJ. Lack of Hierarchical Survival Prognosis in AJCC Staging for Colon and Rectal Cancer-Implications for Future Summary Stage Classification. Clin Colorectal Cancer 24(2):159-165.e2, 2024. e-Pub 2024. PMID: 39730283.
15. Bhutiani, N, Peacock, O, Uppal, A, Hu, C, Bednarski, BK, Taggart, MW, Dasari, NV, Morris, VK, Kaur, H, Kopetz, S, Holliday, EB, Das, P, You, YN, Chang, GJ. The prognostic impact of tumor deposits in colorectal cancer. Cancer 130(23):4052-4060, 2024. e-Pub 2024. PMID: 39306694.
16. Chen RC, Basak R, Dusetzina S, Usinger DS, Mohammed Z, Falchook AD, Schumacher JR, Francescatti AB, Cuddy A, Chang GJ, Kozower BD, Greenberg CC, Barber AK, Katz AJ. Posttreatment surveillance intensity and overall survival in prostate cancer survivors (AFT-30). JNCI Cancer Spectr 8(6), 2024. e-Pub 2024. PMID: 39383199.
17. Agnes A, Nguyen ST, Konishi T, Peacock O, Bednarski BK, You YN, Messick CA, Tillman MM, Skibber JM, Chang GJ, Uppal A. Early Postoperative Prediction of Complications and Readmission After Colorectal Cancer Surgery Using an Artificial Neural Network. Dis Colon Rectum 67(10):1341-1352, 2024. e-Pub 2024. PMID: 38959458.
18. Agnes A, Peacock O, Manisundaram N, Kim Y, Stanietzky N, Vikram R, Bednarski BK, Konishi T, You YN, Chang GJ. The Learning Curve for Robotic Lateral Pelvic Lymph Node Dissection for Rectal Cancer: A View From the West. Dis Colon Rectum 67(10):1281-1290, 2024. e-Pub 2024. PMID: 38959454.
19. Chang GJ, Gunn HJ, Barber AK, Lowenstein LM, Dohan D, Broering J, Dockter T, Tan AD, Dueck A, Chow S, Neuman H, Finlayson E. Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)-Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD). Ann Surg 280(4):623-632, 2024. e-Pub 2024. PMID: 39069901.
20. Shin A, Elmorsi R, Nguyen CM, Baumann D, Adelman DM, Chang GJ, Skibber J, Roubaud MS. Contemporary role of the plastic and reconstructive surgeon in the outcome of female peripelvic defects after oncologic extirpation. J Surg Oncol 130(5):1119-1129, 2024. e-Pub 2024. PMID: 39501499.
21. Conti RM, McCue S, Dockter T, Gunn HJ, Dusetzina SB, Bennett AV, Rapkin B, Gracia G, Jazowski S, Johnson M, Behrens R, Richardson P, Subbiah N, Chow S, Chang GJ, Neuman HB, Weiss ES. Self-Reported Financial Difficulties Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia Treated at U.S. Community Oncology Clinics (Alliance A231602CD). medRxiv, 2024. e-Pub 2024. PMID: 39371185.
22. Benson, AB, Venook, AP, Adam, M, Chang, GJ, Chen, YJ, Ciombor, KK, Cohen, S, Cooper, HS, Deming, DA, Garrido-Laguna, I, Grem, JL, Haste, P, Hecht, JR, Hoffe, S, Hunt, S, Hussan, H, Johung, KL, Joseph, N, Kirilcuk, N, Krishnamurthi, SS, Malla, M, Maratt, JK, Messersmith, WA, Meyerhardt, JA, Miller, ED, Mulcahy, MF, Nurkin, S, Parikh, AR, Patel, H, Pedersen, KS, Saltz, L, Schneider, CJ, Shibata, D, Shogan, BD, Skibber, JM, Sofocleous, CT, Tavakkoli, A, Willet, CG, Wu, CS, Jones, F, Gurski, LA. NCCN GUIDELINES® INSIGHTS. JNCCN Journal of the National Comprehensive Cancer Network 22(6):366-375, 2024. e-Pub 2024. PMID: 39151454.
23. Bhutiani N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, Uppal A, Peacock O, Messick C, White MG, Skibber JM, Bednarski BK, You YN, Chang GJ, Kaur H, Konishi T. Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes. Ann Surg Oncol 31(9):5962-5970, 2024. e-Pub 2024. PMID: 38836917.
24. Brydges, GJ, Chang, GJ, Gan, TJ, Konishi, T, Gottumukkala, V, Uppal, A. Testing Machine Learning Models to Predict Postoperative Ileus after Colorectal Surgery. Current Oncology 31(6):3563-3578, 2024. e-Pub 2024. PMID: 38920745.
25. Miller ED, Klamer BG, Cloyd JM, Pawlik TM, Williams TM, Hitchcock KE, Romesser PB, Mamon HJ, Ng K, Gholami S, Chang GJ, Anker CJ. Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review. Clin Colorectal Cancer 23(2):160-173, 2024. e-Pub 2024. PMID: 38365567.
26. Watt KD, Watt KD, Rolak S, Rolak S, Foley DP, Foley DP, Plichta JK, Plichta JK, Pruthi S, Pruthi S, Farr D, Farr D, Zwald FO, Zwald FO, Carvajal RD, Carvajal RD, Dudek AZ, Dudek AZ, Sanger CB, Sanger CB, Rocco R, Rocco R, Chang GJ, Chang GJ, Dizon DS, Dizon DS, Langstraat CL, Langstraat CL, Teoh D, Teoh D, Agarwal PK, Agarwal PK, Al-Qaoud T, Al-Qaoud T, Eggener S, Eggener S, Kennedy CC, Kennedy CC, D'Cunha J, D'Cunha J, Mohindra NA, Mohindra NA, Stewart S, Stewart S, Habermann TH, Habermann TH, Schuster S, Schuster S, Lunning M, Lunning M, Shah NN, Shah NN, Gertz MA, Gertz MA, Mehta J, Mehta J, Suvannasankha A, Suvannasankha A, Verna E, Verna E, Farr M, Farr M, Blosser CD, Blosser CD, Hammel L, Hammel L, Al-Adra DP, Al-Adra DP. Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion. Transplantation 108(12):2336-2350, 2024. e-Pub 2024. PMID: 38771067.
27. Bhutiani N, Yousef MMG, Yousef A, Zeineddine M, Knafl M, Ratliff O, Fernando UP, Turin A, Zeineddine FA, Jin J, Alfaro-Munoz K, Goldstein D, Chang GJ, Kopetz S, Shen JP, Uppal A. Automated, High-Throughput Platform to Generate a High-Reliability, Comprehensive Rectal Cancer Database. JCO Clin Cancer Inform 8:e2300219, 2024. e-Pub 2024. PMID: 38759125.
28. DiBrito SR, Manisundaram N, Kim Y, Peacock O, Hu CY, Bednarski B, You YN, Uppal A, Tillman M, Konishi T, Kaur H, Palmquist S, Holliday E, Dasari A, Chang GJ. Perioperative and oncological outcomes following robotic en bloc multivisceral resection for colorectal cancer. Colorectal Dis 26(5):949-957, 2024. e-Pub 2024. PMID: 38576073.
29. Lin, K, Chowdhury, S, Zeineddine, MA, Zeineddine, F, Hornstein, N, Villarreal, OE, Maru, DM, Haymaker, CL, Vauthey, JN, Chang, GJ, Bogatenkova, E, Menter, DG, Kopetz, S, Shen, JY. 1 Identification of colorectal cancer cell stemness from single-cell RNA sequencing. Molecular Cancer Research 22(4), 2024. e-Pub 2024. PMID: 38156967.
30. Wolfson JA, Grimes AC, Nuno M, Kerber CL, Ramakrishnan S, Beauchemin M, Dickens D, Levine JM, Roth ME, Scialla M, Woods W, Vargas S, Boayue KB, Chang GJ, Stock W, Hershman D, Curran E, Advani A, O'Dwyer K, Luger S, Liu JJ, Freyer DR, Sung L, Parsons SK. Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL. JCO Oncol Pract 20(4):491-502, 2024. e-Pub 2024. PMID: 38252911.
31. Childers CP, Manisundaram NV, Hu CY, Chang GJ. Modifier 22 Use in Fee-for-Service Medicare. JAMA Surg 159(5):563-569, 2024. e-Pub 2024. PMID: 38506853.
32. Damron EP, McDonald J, Rooney MK, Das P, Ludmir EB, Minsky BD, Messick C, Chang GJ, Morris VK, Holliday EB. Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy. Clin Colorectal Cancer 23(1):85-94, 2024. e-Pub 2024. PMID: 38216367.
33. West, CT, West, MA, Drami, I, Denys, A, Glyn, T, Sutton, PA, Tiernan, J, Behrenbruch, C, Guerra, GR, Waters, PS, Woodward, N, Applin, S, Charles, SJ, Rose, SA, Pape, E, van Ramshorst, GH, Mirnezami, AH, Aalbers, AG, Abdul Aziz, N, Abecasis, N, Abraham-Nordling, M, Akiyoshi, T, Alahmadi, R, Alberda, W, Albert, M, Andric, M, Angeles, MA, Angenete, E, Antoniou, A, Armitage, J, Auer, R, Austin, KK, Aytac, E, Aziz, O, Bacalbasa, N, Baker, RP, Bali, M, Baransi, S, Baseckas, G, Bebington, B, Bedford, M, Bednarski, BK, Beets, GL, Berg, PL, Bergzoll, C, Beynon, J, Biondo, S, Boyle, K, Chang, GJ, Flatmark, K. Beating the empty pelvis syndrome. BMJ open 14(2), 2024. e-Pub 2024. PMID: 38316595.
34. Fox, DA, Bhamidipati, D, Konishi, T, Kaur, H, You, N, Raghav, KS, Ge, PS, Messick, C, Johnson, B, Morris, VK, Thomas, J, Shah, P, Bednarski, BK, Kopetz, S, Chang, GJ, Ludford, K, Higbie, VS, Overman, MJ. Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer. European Journal of Cancer 194, 2023. e-Pub 2023. PMID: 37827065.
35. White MG, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Lutter-Berkova Z, Chang GJ, Futreal A, Wargo JA, Ajami NJ, Kopetz S, You YN. Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant Therapy. Ann Surg 278(4):538-548, 2023. e-Pub 2023. PMID: 37465976.
36. Manisundaram N, DiBrito SR, Hu CY, Kim Y, Wick E, Palis B, Peacock O, Chang GJ. Reporting of Circumferential Resection Margin in Rectal Cancer Surgery. JAMA Surg 158(11):1195-1202, 2023. e-Pub 2023. PMID: 37728906.
37. Rooney, MK, De, BS, Corrigan, KL, Smith, GL, Taniguchi, C, Minsky, B, Ludmir, EB, Koay, EJ, Das, P, Koong, A, Peacock, O, Chang, GJ, You, YN, Morris, VK, Nogueras Gonzalez, G, Holliday, EB. Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma. Clinical colorectal cancer 22(2):211-221, 2023. e-Pub 2023. PMID: 36878805.
38. Childers CP, Uppal A, Tillman M, Chang GJ, Tran Cao HS. ASO Visual Abstract: Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer. Ann Surg Oncol 30(6):3569, 2023. e-Pub 2023. PMID: 37052830.
39. Childers CP, Uppal A, Tillman M, Chang GJ, Tran Cao HS. Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer. Ann Surg Oncol 30(6):3560-3568, 2023. e-Pub 2023. PMID: 36943527.
40. Basch E, Dueck AC, Mitchell SA, Mamon H, Weiser M, Saltz L, Gollub M, Rogak L, Ginos B, Mazza GL, Colgrove B, Chang G, Minasian L, Denicoff A, Thanarajasingam G, Musher B, George T, Venook A, Farma J, O'Reilly E, Meyerhardt JA, Shi Q, Schrag D. Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048). J Clin Oncol 41(21):JCO2300903, 2023. e-Pub 2023. PMID: 37270691.
41. Peacock O, Manisundaram N, Kim Y, Konishi T, Stanietzky N, Vikram R, Bednarski BK, You YN, Chang GJ. Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything. Br J Surg 110(8):985-986, 2023. e-Pub 2023. PMID: 37150892.
42. Pacyna JE, Dueck AC, Chang GJ, Chow S, Paskett ED, Kim S, Tilburt JC. Lessons learned from conducting the first cancer care delivery trial in the Alliance for Clinical Trials in Oncology (Alliance A191402CD). Clin Trials 20(5):17407745231167123, 2023. e-Pub 2023. PMID: 37050880.
43. Chang GJ. Expert Commentary on Lateral Pelvic Sidewall Nodes. Dis Colon Rectum 66(3):358-359, 2023. e-Pub 2023. PMID: 36728390.
44. Martin AN, Tzeng CD, Arvide EM, Skibber JM, Chang GJ, Nancy You YQ, Bednarski BK, Uppal A, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford) 25(3):347-352, 2023. e-Pub 2023. PMID: 36697350.
45. Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Smith GL, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Soto LS, Morris VK. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel) 15(6), 2023. e-Pub 2023. PMID: 36980587.
46. Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, Goldberg J, Al Baghdadi T, Goodman KA, McWilliams RR, Farma JM, George TJ, Kennecke HF, Shergill A, Montemurro M, Nelson GD, Colgrove B, Gordon V, Venook AP, O'Reilly EM, Meyerhardt JA, Dueck AC, Basch E, Chang GJ, Mamon HJ. Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med 389(4):322-334, 2023. e-Pub 2023. PMID: 37272534.
47. Gunther, J, Chadha, AS, Guha, S, Raju, GS, Maru, DM, Munsell, M, Jiang, Y, Yang, P, Felix, E, Clemons, M, Mathew, GG, Singh, PK, Skibber, JM, Rodriguez-Bigas, MA, Chang, GJ, Eng, C, Delclos, ME, Crane, C, Das, P, Krishnan, S. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. Journal of Gastrointestinal Oncology 13(6):2938-2950, 2022. e-Pub 2022. PMID: 36636059.
48. Fahy, M, Kelly, M, Aalbers, AG, Abdul Aziz, N, Abecasis, N, Abraham-Nordling, M, Akiyoshi, T, Alberda, W, Albert, M, Andric, M, Angeles, MA, Angenete, E, Antoniou, A, Auer, R, Austin, KK, Aytac, E, Aziz, O, Bacalbasa, N, Baker, RP, Bali, M, Baransi, S, Baseckas, G, Bebington, B, Bedford, M, Bednarski, BK, Beets, GL, Berg, PL, Bergzoll, C, Beynon, J, Biondo, S, Boyle, K, Bordeianou, L, Brecelj, E, Bremers, AB, Brunner, M, Buchwald, P, Bui, A, Burgess, A, Burger, JW, Burling, D, Burns, E, Campain, NJ, Carvalhal, S, Castro, L, Caycedo-Marulanda, A, Ceelan, W, Chan, KK, Chang, GJ, Flatmark, K, Larsen, SG. Minimum standards of pelvic exenterative practice. British Journal of Surgery 109(12):1251-1263, 2022. e-Pub 2022. PMID: 36170347.
49. Aiken T, Hu CY, Uppal A, Francescatti AB, Fournier KF, Chang GJ, Zafar SN. Peritoneal recurrence after resection for Stage I-III colorectal cancer: A population analysis. J Surg Oncol 127(4):678-687, 2022. e-Pub 2022. PMID: 36519668.
50. Wang, J, Prabhakaran, S, Larach, T, Warrier, S, Bednarski, BK, Ngan, S, Leong, T, Rodriguez-Bigas, MA, Peacock, O, Chang, GJ, Heriot, A, Kong, JC. Treatment strategies for locally recurrent rectal cancer. European Journal of Surgical Oncology 48(11):2292-2298, 2022. e-Pub 2022. PMID: 35637097.
51. Khan, Z, Rooney, MK, Das, P, Ludmir, EB, Koay, EJ, Smith, GL, Taniguchi, C, Minsky, B, Koong, A, Sawakuchi, GO, Beddar, S, Martin, RM, Rodriguez-Bigas, MA, Peacock, O, Chang, GJ, Holliday, EB. Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence. Clinical colorectal cancer 21(3):204-211, 2022. e-Pub 2022. PMID: 35125321.
52. Leitao MM, Kreaden US, Laudone V, Park BJ, Pappou EP, Davis JW, Rice DC, Chang GJ, Rossi EC, Hebert AE, Slee A, Gonen M. The RECOURSE Study: Long-term Oncologic Outcomes Associated with Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, cOlorectal, lUng, or pRoState cancEr: a Systematic Review and meta-analysis. Ann Surg 277(3):387-396, 2022. e-Pub 2022. PMID: 36073772.
53. Schumacher JR, Neuman HB, Yu M, Vanness DJ, Si Y, Burnside ES, Ruddy KJ, Partridge AH, Schrag D, Edge SB, Zhang Y, Jacobs EA, Havlena J, Francescatti AB, Winchester DP, McKellar DP, Spears PA, Kozower BD, Chang GJ, Greenberg CC, Working Group AACBCS. Surveillance imaging vs symptomatic recurrence detection and survival in stage II-III breast cancer (AFT-01). J Natl Cancer Inst 114(10):1371-1379, 2022. e-Pub 2022. PMID: 35913454.
54. Peacock O, Vilar E, Trueba MG, Thirumurthi S, Chang GJ, You YN. Clinically Significant Metachronous Colorectal Pathology Detected Among Young-Onset Colorectal Cancer Survivors: Implications for Post-Resection Surveillance Guidelines. Gastroenterology, 2022. e-Pub 2022. PMID: 35987446.
55. DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
56. Peacock O, Manisundaram N, Dibrito SR, Kim Y, Hu CY, Bednarski BK, Konishi T, Stanietzky N, Vikram R, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer after Total Neoadjuvant Therapy (TNT). Ann Surg 276(4):654-664, 2022. e-Pub 2022. PMID: 35837891.
57. Snyder RA, Hu CY, DiBrito SR, Chang GJ. Association of Medicaid expansion with racial disparities in cancer stage at presentation. Cancer 128(18):3340-3351, 2022. e-Pub 2022. PMID: 35818763.
58. Rogers JE, Woodard TL, Gonzalez GM, Dasari A, Johnson B, Morris VK, Kee B, Vilar E, Nancy You Y, Chang GJ, Bednarski B, Skibber JM, Rodriguez-Bigas MA, Eng C. Colorectal cancer during pregnancy or postpartum: Case series and literature review. Obstet Med 15(2):118-124, 2022. e-Pub 2022. PMID: 35845232.
59. De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
60. Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br J Surg 109(6):489-492, 2022. e-Pub 2022. PMID: 35576377.
61. Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br J Surg, 2022. e-Pub 2022. PMID: 35373260.
62. Uppal A, Helmink B, Grotz TE, Konishi T, Fournier KF, Nguyen S, Taggart MW, Shen JP, Bednarski BK, You YN, Chang GJ. What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers?. Ann Surg Oncol 29(7):4224-4233, 2022. e-Pub 2022. PMID: 35307803.
63. Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, Team D. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract 18(7):OP2100819, 2022. e-Pub 2022. PMID: 35263166.
64. Holliday EB, Morris VK, Johnson B, Eng C, Ludmir EB, Das P, Minsky BD, Taniguchi C, Smith GL, Koay EJ, Koong AC, Delclos ME, Skibber JM, Rodriguez-Bigas MA, You YN, Bednarski BK, Tillman MM, Chang GJ, Jennings K, Messick CA. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. Oncologist 27(1):40-47, 2022. e-Pub 2022. PMID: 35305097.
65. You YN, Moskowitz J, Chang GJ, Mork M, Rodriguez-Bigas M, Bednarski BK, Messick C, Tillman M, Skibber J, Nguyen S, Kopetz S, Vilar E. Germline Cancer Risk Profiles of Young-Onset Colorectal Cancer Patients: Findings from a Prospective Universal Germline Testing and Tele-Genetics Program. Dis Colon Rectum 66(4):531-542, 2022. e-Pub 2022. PMID: 35195555.
66. You YN, Dasari A, Chang GJ. Report from American Society of Clinical Oncology Symposium 2020 and American Society of Clinical Oncology Gastrointestinal Cancer Symposium 2021. Dis Colon Rectum 65(1):8-10, 2022. e-Pub 2022. PMID: 34784317.
67. Ruiz-Tovar J, Boermeester MA, Bordeianou L, Chang GJ, Gorgun E, Justinger C, Lawson EH, Leaper DJ, Mahmoud NN, Mantyh C, McGee MF, Nfonsam V, Rubio-Perez I, Wick EC, Hedrick TL, Facilitating Group CD. Delphi Consensus on Intraoperative Technical/Surgical Aspects to Prevent Surgical Site Infection after Colorectal Surgery. J Am Coll Surg 234(1):1-11, 2022. e-Pub 2022. PMID: 35213454.
68. Tilburt JC, Zahrieh D, Pacyna JE, Petereit DG, Kaur JS, Rapkin BD, Grubb RL, Chang GJ, Morris MJ, Kovac EZ, Babaian KN, Sloan JA, Basch EM, Peil ES, Dueck AC, Novotny PJ, Paskett ED, Buckner JC, Joyce DD, Montori VM, Frosch DL, Volk RJ, Kim SP. Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD). Cancer 128(6):1242-1251, 2021. e-Pub 2021. PMID: 34890060.
69. Erstad DJ, Dasari A, Taggart MW, Kaur H, Konishi T, Bednarski BK, Chang GJ. Prognosis for Poorly Differentiated, High-Grade Rectal Neuroendocrine Carcinomas. Ann Surg Oncol 29(4):2539-2548, 2021. e-Pub 2021. PMID: 34787737.
70. Vogel JD, Felder SI, Bhama AR, Hawkins AT, Langenfeld SJ, Shaffer VO, Thorsen AJ, Weiser MR, Chang GJ, Lightner AL, Feingold DL, Paquette IM. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer. Dis Colon Rectum 65(2):148-177, 2021. e-Pub 2021. PMID: 34775402.
71. Taku N, Yi-Qian YN, Chang GJ, Ludmir EB, Raghav KPS, Rodriguez-Bigas MA, Holliday EB, Smith GL, Minsky BD, Overman MJ, Messick C, Boyce-Fappiano D, Koong AC, Skibber JM, Koay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Kopetz S, Das P. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer 21(1):e28-e37, 2021. e-Pub 2021. PMID: 34794903.
72. Nofal S, You YN, Chang GJ, Grubbs EG, Bednarski B. Development of an Online Curriculum for Surgeons on the Use of Pelvic Magnetic Resonance Imaging in Rectal Cancer and Results of a Pilot Study. J Surg Res 270:279-285, 2021. e-Pub 2021. PMID: 34717261.
73. Swords DS, Bednarski BK, Messick CA, Tillman MM, Chang GJ, You YN. Quality and Location of the Surgical Episode Mediate a Large Proportion of Socioeconomic-Based Survival Disparities in Patients with Resected Stage I-III Colon Cancer. Ann Surg Oncol 29(1):706-716, 2021. e-Pub 2021. PMID: 34406541.
74. Kothari AN, Chang GJ. ASO Author Reflections: Leveraging Real-World Data to Guide Surgical Risk Stratification in Patients Recovered from COVID-19. Ann Surg Oncol 28(13):8054-8055, 2021. e-Pub 2021. PMID: 34304311.
75. Kroon HM, Kusters M, Chang GJ, Sammour T. Reply to: Lateral lymph node dissection in low rectal cancers: Call for standardized reporting of results to unify the global practice. Eur J Surg Oncol 47(9):2477-2478, 2021. e-Pub 2021. PMID: 34244051.
76. Kothari AN, DiBrito SR, Lee JJ, Caudle AS, Clemens MW, Gottumukkala VN, Katz MHG, Offodile AC, Uppal A, Team D, Chang GJ. Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection. Ann Surg Oncol 28(13):8046-8053, 2021. e-Pub 2021. PMID: 34176060.
77. Zuckerman SL, Lee SH, Chang GJ, Walsh GL, Mehran RJ, Gokaslan ZL, Rao G, Tatsui CE, Rhines LD. Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients With Long-Term Follow-Up. Global Spine J 11(5):740-750, 2021. e-Pub 2021. PMID: 34047643.
78. Kroon HM, Malakorn S, Dudi-Venkata NN, Bedrikovetski S, Liu J, Kenyon-Smith T, Bednarski BK, Ogura A, van de Velde CJH, Rutten HJT, Beets GL, Thomas ML, Kusters M, Chang GJ, Sammour T. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study. Eur J Surg Oncol 47(9):2441-2449, 2021. e-Pub 2021. PMID: 34120810.
79. Collaborative P. Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II). BJS Open 5(3), 2021. e-Pub 2021. PMID: 34089596.
80. Hester R, Advani S, Rashid A, Holliday E, Messick C, Das P, You YN, Taniguchi C, Koay EJ, Bednarski B, Rodriguez-Bigas M, Skibber J, Wolff R, Chang GJ, Minsky BD, Foo WC, Rothschild N, Morris VK, Eng C. CEA as a blood-based biomarker in anal cancer. Oncotarget 12(11):1037-1045, 2021. e-Pub 2021. PMID: 34084278.
81. Ludford K, Cohen R, Svrcek M, Foo WC, Colle R, Parc Y, Thomas JV, Morris VK, Kopetz S, Chang GJ, Overman M, Andre T. Pathological tumor response following immune checkpoint blockade for deficient mismatch repair advanced colorectal cancer. J Natl Cancer Inst 113(2):208-211, 2021. e-Pub 2021. PMID: 32294214.
82. Chok, AY, Oliver, A, Rasheed, S, Tan, E, Kelly, M, Aalbers, AG, Abdul Aziz, N, Abecasis, N, Abraham-Nordling, M, Akiyoshi, T, Alberda, W, Albert, M, Andric, M, Angenete, E, Antoniou, A, Auer, R, Austin, KK, Aziz, O, Baker, RP, Bali, M, Baseckas, G, Bebington, B, Bedford, M, Bednarski, BK, Beets, GL, Berg, PL, Beynon, J, Biondo, S, Boyle, K, Bordeianou, L, Bremers, AB, Brunner, M, Buchwald, P, Bui, A, Burgess, A, Burger, JW, Burling, D, Burns, E, Campain, NJ, Carvalhal, S, Castro, L, Caycedo-Marulanda, A, Chan, KK, Chang, GJ, Chew, MH, Chong, P, Christensen, HK, Clouston, H, Flatmark, K, Larsen, SG. Perioperative management and anaesthetic considerations in pelvic exenterations using Delphi methodology. BJS open 5(1), 2021. e-Pub 2021. PMID: 33609393.
83. Kothari AN, Trans AT, Caudle AS, Clemens MW, Katz MHG, Woodman SE, Chang GJ. Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges. Br J Surg 108(1):e24-e26, 2021. e-Pub 2021. PMID: 33640925.
84. Dudurych, I, Kelly, M, Aalbers, AG, Abdul Aziz, N, Abecasis, N, Abraham-Nordling, M, Akiyoshi, T, Alberda, W, Albert, M, Andric, M, Angenete, E, Antoniou, A, Auer, R, Austin, KK, Aziz, O, Baker, RP, Bali, M, Baseckas, G, Bebington, B, Bedford, M, Bednarski, BK, Beets, GL, Berg, PL, Beynon, J, Biondo, S, Boyle, K, Bordeianou, L, Bremers, AB, Brunner, M, Buchwald, P, Bui, A, Burgess, A, Burger, JW, Burling, D, Burns, E, Campain, NJ, Carvalhal, S, Castro, L, Caycedo-Marulanda, A, Chan, KK, Chang, GJ, Chew, MH, Chok, AK, Chong, P, Christensen, HK, Clouston, H, Codd, M, Collins, D, Flatmark, K, Larsen, SG. Predicting outcomes of pelvic exenteration using machine learning. Colorectal Disease 22(12):1933-1940, 2020. e-Pub 2020. PMID: 32627312.
85. Bellato V, Konishi T, Pellino G, An Y, Piciocchi A, Sensi B, Siragusa L, Khanna K, Pirozzi BM, Franceschilli M, Campanelli M, Efetov S, Sica GS, Group SC. Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practices. J Glob Health 10(2):020507, 2020. e-Pub 2020. PMID: 33110590.
86. Healy MA, Peacock O, Hu CY, Bednarski BK, Tillman MM, Messick C, Kaur H, Chang GJ. High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action. Ann Surg, 2020. e-Pub 2020. PMID: 33630474.
87. Snyder RA, Hu CY, Zafar SN, Francescatti A, Chang GJ. Racial Disparities in Recurrence and Overall Survival in Patients with Locoregional Colorectal Cancer. J Natl Cancer Inst 113(6):770-777, 2020. e-Pub 2020. PMID: 33231683.
88. An Y, Bellato V, Konishi T, Pellino G, Sensi B, Siragusa L, Franceschilli M, Sica GS, Group SC. Surgeons' fear of getting infected by COVID19: A global survey. Br J Surg 107(11):e543-e544, 2020. e-Pub 2020. PMID: 32808678.
89. Collaborative P. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. Colorectal Dis 22(10):1258-1262, 2020. e-Pub 2020. PMID: 32294308.
90. Peacock O, Chang GJ. Is the learning curve the Achilles heel of surgical innovation?—arguments against TaTME. Annals of Laparocopic and Endoscopic Surgery 5, 2020. e-Pub 2020.
91. Collaborative P. The global cost of pelvic exenteration: in-hospital perioperative costs. Br J Surg 107(11):e470-e471, 2020. e-Pub 2020. PMID: 33460051.
92. Peacock O, Limvorapitak T, Bednarski BK, Kaur H, Taggart MW, Dasari A, Holliday EB, Minsky BD, Nancy You Y, Chang GJ. Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: A Western perspective. Colorectal Dis 22(12):2049-2056, 2020. e-Pub 2020. PMID: 32892473.
93. Peacock O, Limvorapitak T, Hu CY, Bednarski BK, Tillman MM, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes. Br J Surg 107(12):1552-1557, 2020. e-Pub 2020. PMID: 32996597.
94. Bellato V, Konishi T, Pellino G, An Y, Piciocchi A, Sensi B, Siragusa L, Khanna K, Pirozzi BM, Franceschilli M, Campanelli M, Efetov S, Sica GS, Group SC. Impact of asymptomatic COVID-19 patients in global surgical practice during the COVID-19 pandemic. Br J Surg 107(10):e364-e365, 2020. e-Pub 2020. PMID: 32767367.
95. Collaborative P. The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer. Br J Surg 107(11):e547-e548, 2020. e-Pub 2020. PMID: 32779191.
96. Malakorn S, Ouchi A, Hu CY, Sandhu L, Dasari A, You YN, Kopetz ES, Ellis LM, Chang GJ. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer. Clin Colorectal Cancer 20(1):e53-e60, 2020. e-Pub 2020. PMID: 33004292.
97. Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA, WHO Classification of Tumours Editorial Board WHO. Diagnosis of Digestive System Tumours. Int J Cancer 148(5):1040-1050, 2020. e-Pub 2020. PMID: 32674220.
98. Patel SH, Hu CY, Massarweh NN, You YN, McCabe R, Dietz D, Facktor MA, Chang GJ. Circumferential Resection Margin as a Hospital Quality Assessment Tool for Rectal Cancer Surgery. J Am Coll Surg 230(6):1008-1018.e5, 2020. e-Pub 2020. PMID: 32142927.
99. Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 19(2):116-122, 2020. e-Pub 2020. PMID: 32173279.
100. Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership. J Surg Oncol 122(6):1066-1073, 2020. e-Pub 2020. PMID: 32632993.
101. Kim MJ, Chang GJ, Lim HK, Song MK, Park SC, Sohn DK, Chang HJ, Kim DY, Park JW, Jeong SY, Oh JH. Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer. Ann Surg Oncol 27(9):3525-3533, 2020. e-Pub 2020. PMID: 32385767.
102. Ge PS, Angsuwatcharakon P, Chang GJ, Foo WC, Tillman MM, Aihara H. The suture pulley countertraction method for challenging rectal endoscopic submucosal dissection. VideoGIE 5(5):210-212, 2020. e-Pub 2020. PMID: 32426573.
103. Chang GJ, Holliday EB, Malakorn S. The Authors Reply. Dis Colon Rectum 63(4):e43, 2020. e-Pub 2020. PMID: 32132468.
104. Snyder RA, Fournier K, Royal R, Venook AP, Chang GJ. Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence. Clin Colorectal Cancer 19(1):1-4, 2020. e-Pub 2020. PMID: 31983613.
105. Yang Y, Peacock O, Malakorn S, Limvorapitak T, Zafar SN, Chang GJ. Superior Mesenteric Vein-First Approach for Robotic Salvage Surgery with Indocyanine Green Fluorescence Angiography. Ann Surg Oncol 27(9):3500, 2020. e-Pub 2020. PMID: 32144622.
106. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20-mm colon polyps. Endosc Int Open 7(3):E361-E366, 2020. e-Pub 2020. PMID: 30834295.
107. Zafar SN, Hu CY, Snyder RA, Cuddy A, You YN, Lowenstein LM, Volk RJ, Chang GJ. Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study. Ann Surg Oncol 27(8):2740-2749, 2020. e-Pub 2020. PMID: 32080809.
108. Chang GJ, You YNY, Russell CA, Tierno MB, Turner M, Bennett JP, Lau A, Hochster HS. Young-Onset Colon Cancer and Recurrence Risk By Gene Expression. J Natl Cancer Inst 112(11):1170-1173, 2020. e-Pub 2020. PMID: 32040172.
109. Kelly ME, Collaborative P. Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx collaborative. Colorectal Dis 22(9):1184-1188, 2020. e-Pub 2020. PMID: 32043753.
110. Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R, Hagan K, Davila M, Stroehlein J. Cap-fitted endoscopic mucosal resection of =?20?mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 8(2):E115-E121, 2020. e-Pub 2020. PMID: 32010742.
111. Kelly, M, Ryan, J, Aalbers, AG, Abdul, AN, Abraham-Nordling, M, Alberda, W, Antoniou, A, Austin, KK, Baker, RP, Bali, M, Baseckas, G, Bednarski, BK, Beets, GL, Berg, PL, Beynon, J, Biondo, S, Bordeianou, L, Bremers, AB, Brunner, M, Buchwald, P, Burger, JW, Burling, D, Campain, NJ, Chan, KK, Chang, GJ, Chew, MH, Chong, CP, Christensen, HK, Codd, M, Colquhoun, AJ, Corr, A, Coscia, M, Coyne, PE, Creavin, B, Damjanovic, L, Daniels, IR, Davies, M, Davies, RJ, Dewilt, JH, Denost, Q, Deutsch, C, Dietz, DW, Domingo, S, Dozois, EJ, Duff, M, Eglinton, T, Evans, MD, Fearnhead, NS, Frizelle, F, Garcia-Granero, E, García-Sabrido, JL, Gentilini, L, George, ML, Glynn, R, Golda, T, Griffiths, B, Harris, DA, Evans, MD, Hagemans, JA, Harji, DP, Heriot, A, Hohenberger, W, Holm, T, Humphries, E, Jansson-Palmer, G, Jenkins, JT, Kapur, S, Kanemitsu, Y, Kelley, SR, Keller, DS, Kim, HJ, Koh, CE, Kok, NF, Kokelaar, R, Kontovounisios, C, Kroon, HM, Kusters, M, Lago, V, Larson, DW, Law, WL, Laurberg, S, Lee, PJ, Lydrup, ML, Lynch, AC, Mathis, KL, Martling, A, Meijerink, WJ, Merkel, S, Mehta, AM, McDermott, FD, McGrath, JS, Mihailo, A, Mirnezami, AH, Morton, JR, Mullaney, TG, Nielsen, MB, Nieuwenhuijzen, GA, Nilsson, PJ, O'Connell, PR, Palmer, G, Patsouras, D, Pellino, G, Poggioli, G, Quinn, M, Quyn, A, Radwan, RW, Rasheed, S, Rasmussen, PC, Rocha, R, Rothbarth, J, Roxburgh, C, Rutten, H, Sagar, P, Sammour, T, Schizas, AM, Schwarzkopf, E, Scripcariu, V, Shaikh, I, Shida, D, Simpson, A, Smart, N, Smith, JJ, Solomon, MJ, Sørensen, MM, Steele, SR, Steffens, D, Stocchi, L, Stylianides, NA, Tekkis, P, Taylor, C, Tsukamoto, S, Turner, WH, Tuynman, JB, Vanramshorst, GH, Van, ZD, Vasquez-Jimenez, W, Verhoef, C, Wakeman, C, Warrier, S, Wasmuth, H, Weiser, M, Wheeler, JM, Wild, J, Yip, J, Winter, DC. Pelvic exenteration for advanced nonrectal pelvic malignancy. Annals of surgery 270(5):899-905, 2019. e-Pub 2019. PMID: 31634184.
112. Nofal S, You YN, GJ|| C, Grubbs EE, Bednarski BK. Residents entering Complex General Surgical Oncology fellowship lack confidence with pelvic MRI for rectal cancer: Results of a needs assessment survey. Am J Surg 219(2):304-308, 2019. e-Pub 2019. PMID: 31753316.
113. Massarweh NN, Chang GJ. Translating Research Findings Into Practice-The Unfulfilled and Unclear Mission of Observational Data. JAMA Surg 154(2):103-104, 2019. e-Pub 2019. PMID: 30422255.
114. Eng C, Jácome AA, Das P, Chang GJ, Rodriguez-Bigas M, Skibber JM, Wolff RA, Qiao W, Xing Y, Sethi S, Ohinata A, Crane CH. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal. Clin Colorectal Cancer 18(4):301-306, 2019. e-Pub 2019. PMID: 31350201.
115. Malakorn S, Yang Y, Bednarski BK, Kaur H, You YN, Holliday EB, Dasari A, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?. Dis Colon Rectum 62(10):1158-1166, 2019. e-Pub 2019. PMID: 31490825.
116. Peacock O, Chang GJ. "Watch and Wait" for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer. Minerva Chir 74(6):481-495, 2019. e-Pub 2019. PMID: 31580047.
117. Kelly, M, Aalbers, AG, Aziz, NA, Abraham-Nordling, M, Alberda, W, Antoniou, A, Austin, KK, Baker, RP, Bali, M, Baseckas, G, Bednarski, BK, Beets, GL, Berg, PL, Beynon, J, Biondo, S, Bordeianou, L, Brunner, M, Buchwald, P, Burger, JW, Burling, D, Campain, NJ, Chan, KK, Chang, GJ, Chew, MH, Chong, P, Christensen, HK, Codd, M, Colquhoun, AJ, Corr, A, Coscia, M, Coyne, PE, Creavin, B, Damjanovic, L, Daniels, IR, Davies, M, Davies, RJ, de Wilt, JH, Denost, Q, Deutsch, C, Dietz, DW, Dozois, EJ, Duff, M, Eglinton, T, Evans, MD, Evans, MD, Fearnhead, NS, Frizelle, F, Garcia-Granero, E, García-Sabrido, JL, Gentilini, L. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer. BJS open 3(4):516-520, 2019. e-Pub 2019. PMID: 31388644.
118. Lowenstein LM, Volk RJ, Cuddy A, Hempstead AP, You YN, Van Loon K, Millas S, Meyerhardt JA, Gavin P, Chang GJ. Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study. BMJ Open 9(8):e025888, 2019. e-Pub 2019. PMID: 31420381.
119. Yang Y, Malakorn S, Zafar SN, Nickerson TP, Sandhu L, Chang GJ. Superior Mesenteric Vein-First Approach to Robotic Complete Mesocolic Excision for Right Colectomy: Technique and Preliminary Outcomes. Dis Colon Rectum 62(7):894-897, 2019. e-Pub 2019. PMID: 31188192.
120. Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick CA, Taggart M, Chang GJ, You YN. Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk benefit equation. Colorectal Dis 22(1):53-61, 2019. e-Pub 2019. PMID: 31356721.
121. van der Velden, DL, Levit, L, Chang, GJ, Facktor, MA, Goodman, KA, Kaufman, J, Konecny, GE, Kwan, SW, Mooney, M, Smith, GL, Solomon, S, Tam, AL, Waterhouse, DM, Voest, EE. When oncologic treatment options outpace the existing evidence. Journal of Cancer Policy 20, 2019. e-Pub 2019.
122. Bednarski BK, Nickerson TP, You YN, Messick CA, Speer B, Gottumukkala V, Manandhar M, Weldon M, Dean EM, Qiao W, Wang X, Chang GJ. Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial). Br J Surg 106(10):1311-1318, 2019. e-Pub 2019. PMID: 31216065.
123. Yang Y, Malakorn S, Maldonado K, Bednarski BK, Kiernan CM, Thirumurthi S, Chang GJ, You YN. The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon. Ann Surg Oncol 26(8):2514-2515, 2019. e-Pub 2019. PMID: 31102088.
124. Halverson AL, Morris AM, Cleary RK, Chang GJ. For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection?. Ann Surg Oncol 26(8):2497-2506, 2019. e-Pub 2019. PMID: 31025228.
125. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR, Maun DC, Chang GJ, Herline A, Fichera A, Mutch MG, Wexner SD, Whiteford MH, Marks J, Birnbaum E, Margolin DA, Larson DW, Marcello PW, Posner MC, Read TE, Monson JRT, Wren SM, Pisters PWT, Nelson H. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: Follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 269(4):589-595, 2019. e-Pub 2019. PMID: 30080730.
126. You YN, Borras E, Chang K, Price BA, Mork M, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Meric-Bernstam F, Vilar E. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum 62(4):429-437, 2019. e-Pub 2019. PMID: 30730459.
127. Subramanian M, Liu J, Greenberg C, Schumacher J, Chang GJ, McMurry TL, Francescatti AB, Semenkovich TR, Hudson JL, Meyers BF, Puri V, Kozower BD. Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?. J Thorac Cardiovasc Surg 157(3):1205-1217.e2, 2019. e-Pub 2019. PMID: 31130741.
128. Sammour T, Chang GJ. Robotic surgery for rectal cancer: the future?. Minerva Chir 73(6):574-578, 2018. e-Pub 2018. PMID: 29806755.
129. Cleary RK, Morris AM, Chang GJ, Halverson AL. Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach?. Ann Surg Oncol 25(12):3587-3595, 2018. e-Pub 2018. PMID: 30187281.
130. Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, Wind JK, Shaw MC, Heon N, Shi Q, Ginos B, Nelson GD, Meyers JP, Chang GJ, Mamon HJ, Weiser MR, Kolevska T, Reeve BB, Bruner DW, Schrag D. Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. J Clin Oncol 36(31):JCO2018788620, 2018. e-Pub 2018. PMID: 30204536.
131. McMurry TL, Stukenborg GJ, Kessler LG, Colditz GA, Wong ML, Francescatti AB, Jones DR, Schumacher JR, Greenberg CC, Chang GJ, Winchester DP, McKellar DP, Kozower BD. More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study. Ann Surg 268(4):632-639, 2018. e-Pub 2018. PMID: 30004919.
132. Wong ML, McMurry TL, Schumacher JR, Hu CY, Stukenborg GJ, Francescatti AB, Greenberg CC, Chang GJ, McKellar DP, Walter LC, Kozower BD. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03). J Oncol Pract 14(10):JOP1800175, 2018. e-Pub 2018. PMID: 30207852.
133. Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol 3(4):595-600, 2018. e-Pub 2018. PMID: 30370360.
134. Berian JR, Cuddy A, Francescatti AB, O'Dwyer L, Nancy You Y, Volk RJ, Chang GJ. Correction to: A systematic review of patient perspectives on surveillance after colorectal cancer treatment. J Cancer Surviv 12(5):721, 2018. e-Pub 2018. PMID: 29951829.
135. Sammour T, Chang GJ. Lateral Pelvic Lymph Node Dissection and Radiation Treatment for Rectal Cancer: Mutually Exclusive or Mutually Beneficial?. Ann Gastroenterol Surg 2(5):348-350, 2018. e-Pub 2018. PMID: 30238075.
136. Kolarich A, George TJ, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer 124(17):3510-3519, 2018. e-Pub 2018. PMID: 29984547.
137. Malakorn S, Ouchi A, Sammour T, Bednarski BK, Chang GJ. Robotic Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation: View from the West. Dis Colon Rectum 61(9):1119-1120, 2018. e-Pub 2018. PMID: 30086062.
138. Pacyna JE, Kim S, Yost K, Sedlacek H, Petereit D, Kaur J, Rapkin B, Grubb R, Paskett E, Chang GJ Sloan J, Basch E, Major B, Novotny P, Taylor J, Buckner J, Parsons JK, Morris M, Tilburt JC. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD. BMC Cancer 18(1):788, 2018. e-Pub 2018. PMID: 30081846.
139. Mason MC, Tran Cao HS, Awad SS, Farjah F, Chang GJ, Massarweh NN. Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg 268(2):303-310, 2018. e-Pub 2018. PMID: 28498235.
140. Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You YQ, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol 41(7):632-637, 2018. e-Pub 2018. PMID: 27755060.
141. Sada YH, Tran Cao HS, Chang GJ, Artinyan A, Musher BL, Smaglo BG, Massarweh NN. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res 226:15-23, 2018. e-Pub 2018. PMID: 29661280.
142. Delitto D, George TJ, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst 110(5):460-466, 2018. e-Pub 2018. PMID: 29165692.
143. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ, Working Group AFCTIONCSO. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA 319(20):2104-2115, 2018. e-Pub 2018. PMID: 29800181.
144. Patel A, Chang GJ, Wale A, Rutten H, Nicholls J, Hawkins M, Steele RJC, Marks J, Brown G. Intra-operative radiotherapy-creating new surgical boundries. Colorectal Disease 20:65-75, 2018. e-Pub 2018. PMID: 29878668.
145. Patel A, Chang G, Wale A, Chong I, Rutten H, Nicholls J, Hawkins M, Steele RJC, Marks J, Brown G. Session 3: Intra-operative radiotherapy - creating new surgical boundaries. Colorectal Dis 20 Suppl 1:65-75, 2018. e-Pub 2018. PMID: 29878668.
146. Ali SM, Pawlik TM, Rodriguez-Bigas MA, Monson JRT, Chang GJ, Larson DW. Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis. Ann Surg Oncol 25(1):32-37, 2018. e-Pub 2018. PMID: 28224365.
147. Loehrer AP, Chang DC, Song Z, Chang GJ. Health Reform and Utilization of High-Volume Hospitals for Complex Cancer Operations. J Oncol Pract 14(1):e42-e50, 2018. e-Pub 2018. PMID: 29155612.
148. Paquette IM, Madoff RD, Sigurdson ER, Chang GJ. Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Ann Surg Oncol 25(1):38-45, 2018. e-Pub 2018. PMID: 27942902.
149. Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 8(6):990-997, 2017. e-Pub 2017. PMID: 29299359.
150. Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. Ann Surg Oncol 24(13):4051-4058, 2017. e-Pub 2017. PMID: 28936799.
151. Carlos RC, Sicks JD, Chang GJ, Lyss AP, Stewart TL, Sung L, Weaver KE. Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners. J Am Coll Radiol 14(12):1530-1537, 2017. e-Pub 2017. PMID: 29055605.
152. Voong KR, Rashid A, Crane CH, Minsky BD, Krishnan S, Yao JC, Wolff RA, Skibber JM, Feig BW, Chang GJ, Das P. Chemoradiation for High Grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Am J Clin Oncol 40(6):555-560, 2017. e-Pub 2017. PMID: 26237193.
153. Mason MC, Chang GJ, Petersen LA, Sada YH, Tran Cao HS, Chai C, Berger DH, Massarweh NN. National Quality Forum Colon Cancer Quality Metric Performance: How Are Hospitals Measuring Up?. Ann Surg 266(6):1013-1020, 2017. e-Pub 2017. PMID: 27617852.
154. Cata JP, Guerra CE, Chang GJ, Gottumukkala V, Joshi GP. Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. Br J Anaesth 119(4):750-764, 2017. e-Pub 2017. PMID: 29121285.
155. You YN, Shiozaki H, Lee JE, Passot G, Goumard C, Okuno M, Aloia TA, Eng C, Chang GJ, Vauthey JN, Conrad C. Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection. Ann Surg Oncol 24(9):2595, 2017. e-Pub 2017. PMID: 28510798.
156. Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol 35(23):JCO2016721464, 2017. e-Pub 2017. PMID: 28657814.
157. Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol 2(3):455-464, 2017. e-Pub 2017. PMID: 29114614.
158. Price BA, Bednarski BK, You YN, Manandhar M, Dean EM, Alawadi ZM, Bryce Speer B, Gottumukkala V, Weldon M, Massey RL, Wang X, Qiao W, Chang GJ. Accelerated Enhanced Recovery following Minimally Invasive Colorectal Cancer Surgery (RecoverMI): A Study Protocol for a Novel Randomised Controlled Trial. BMJ Open 7(7):e015960, 2017. e-Pub 2017. PMID: 28729319.
159. Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal. Ann Surg Oncol 24(7):1904-1915, 2017. e-Pub 2017. PMID: 28324284.
160. Malakorn S, Sammour T, Bednarski B, You YN, Chang GJ. Three Different Approaches to the Inferior Mesenteric Artery during Robotic D3 Lymphadenectomy for Rectal Cancer. Ann Surg Oncol 24(7):1923, 2017. e-Pub 2017. PMID: 28213788.
161. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and Functional Hazards of Obesity among Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol 40(3):277-282, 2017. e-Pub 2017. PMID: 27028350.
162. Malakorn S, Sammour T, Pisters LL, Chang GJ. Robotic Total Pelvic Exenteration. Dis Colon Rectum 60(5):555, 2017. e-Pub 2017. PMID: 28383456.
163. Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer 123(7):1124-1133, 2017. e-Pub 2017. PMID: 27479827.
164. Sturgeon JD, Crane CH, Krishnan S, Minsky BD, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol 40(2):163-166, 2017. e-Pub 2017. PMID: 25222072.
165. Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractioned Accelerated Reirradiation for Rectal Cancer. An Analysis of Outcomes and Toxicity. Radiother Oncol 122(1):146-151, 2017. e-Pub 2017. PMID: 28057329.
166. Wong ML, McMurry TL, Stukenborg GJ, Francescatti AB, Amato-Martz C, Schumacher JR, Chang GJ, Greenberg CC, Winchester DP, McKellar DP, Walter LC, Kozower BD. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study. Lung Cancer 102:108-117, 2016. e-Pub 2016. PMID: 27987578.
167. Liu C, Eng C, Shen J, Lu Y, Yoko T, Mehdizadeh A, Chang GJ, Rodriguez-Bigas MA, Li Y, Chang P, Mao Y, Hassan MM, Wang F, Li D. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget, 2016. e-Pub 2016.
168. de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol 34(25):3039-3046, 2016. e-Pub 2016. PMID: 27432916.
169. Schwarz L, Aloia TA, Eng C, Chang GJ, Vauthey JN, Conrad C. Transthoracic Port Placement Increases Safety of Total Laparoscopic Posterior Sectionectomy. Ann Surg Oncol 23(7):2167, 2016. e-Pub 2016. PMID: 26903047.
170. Glasgow SC, Morris AM, Baxter NN, Fleshman JW, Alavi KS, Luchtefeld MA, Monson JR, Chang GJ, Temple LK. Development of The American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist. Dis Colon Rectum 59(7):601-6, 2016. e-Pub 2016. PMID: 27270511.
171. Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick C, Maru DM, Dean EM, Nguyen ST, Hu CY, Chang GJ. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Ann Surg Oncol 23(7):2249-57, 2016. e-Pub 2016. PMID: 26856720.
172. Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc 84(1):115-125.e4, 2016. e-Pub 2016. PMID: 26769407.
173. Yamasaki A, Mise Y, Mise Y, Lee JE, Aloia TA, Katz MH, Chang GJ, Lillemoe KD, Raut CP, Conrad C. Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. Surgery 159(5):1260-8, 2016. e-Pub 2016. PMID: 26706609.
174. You YN, Skibber JM, Hu CY, Crane CH, Das P, Kopetz ES, Eng C, Feig BW, Rodriguez-Bigas MA, Chang GJ. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg 103(6):753-762, 2016. e-Pub 2016. PMID: 26933792.
175. Liu, C, Eng, C, Shen, J, Lu, Y, Yoko, T, Mehdizadeh, A, Chang, GJ, Rodriguez-Bigas, MA, Li, Y, Chang, P, Mao, YX, Hassan, MM, Wang, F, Li, D. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget 7(46):76250-76260, 2016. e-Pub 2016. PMID: 27788488.
176. Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ, Cancer (OSTRiCh) CFOTTOR. High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. Ann Surg 262(6):891-8, 2015. e-Pub 2015. PMID: 26473651.
177. Patel S, Chang GJ. Primary Tumor Resection in Metastatic Colorectal Cancer: Please Pass the Salt. JAMA Oncol 1(9):1213-4, 2015. e-Pub 2015. PMID: 26378904.
178. Morris VK, Rashid A, Rodriguez-Bigas M, Das P, Chang GJ, Ohinata A, Rogers J, Crane C, Wolff RA, Eng C. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncologist 20(11):1247-52, 2015. e-Pub 2015. PMID: 26382740.
179. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR, Maun D, Chang GJ, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA 314(13):1346-55, 2015. e-Pub 2015. PMID: 26441179.
180. Massarweh NN, Haynes AB, Chiang YJ, Chang GJ, You YN, Feig BW, Cormier JN. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?. Ann Surg 262(2):312-20, 2015. e-Pub 2015. PMID: 25185467.
181. Hu CY, Bailey CE, Chang GJ. Less Surgery, Improved Survival From Stage IV Colorectal Cancer?-Reply. JAMA Surg 150(8):819-20, 2015. e-Pub 2015. PMID: 26107989.
182. Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, Hoff P, Tran H, Menter DG, Heymach J, Overman M, Kopetz S. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer 112(6):1088-97, 2015. e-Pub 2015. PMID: 25688736.
183. Bailey CE, Tran Cao HS, Hu CY, Chang GJ, Feig BW, Rodriguez-Bigas MA, Nguyen ST, Skibber JM, You YN. Functional Deficits and Symptoms of Long-Term Survivors of Colorectal Cancer Treated by Multimodality Therapy Differ by Age at Diagnosis. J Gastrointest Surg 19(1):180-8, 2015. e-Pub 2015. PMID: 25213581.
184. Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart M, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw 13(7):865-72, 2015. e-Pub 2015. PMID: 26150580.
185. Bailey CE, Hu CY, You YN, Kaur H, Ernst RD, Chang GJ. Variation in Positron Emission Tomography Use After Colon Cancer Resection. J Oncol Pract 11(3):e363-72, 2015. e-Pub 2015. PMID: 25852143.
186. Kneuertz PJ, GJ C, Hu CY, Rodriguez-Bigas MA, Eng C, Vilar E, Skibber JM, Feig BW, Cormier JN, You YN. Overtreatment of Young Adults With Colon Cancer: More Intense Treatments With Unmatched Survival Gains. JAMA Surg 150(5):402-9, 2015. e-Pub 2015. PMID: 25806815.
187. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010. JAMA Surg 150(1):1-6, 2015. e-Pub 2015. PMID: 25372703.
188. Hu CY, Bailey CE, You YN, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Time Trend Analysis of Primary Tumor Resection for Stage IV Colorectal Cancer: Less Surgery, Improved Survival. JAMA Surg 150(3):245-51, 2015. e-Pub 2015. PMID: 25588105.
189. Zheng Z, Jemal A, Lin CC, Hu CY, Chang GJ. Comparative Effectiveness of Laparoscopy vs. Open Colectomy Among Non-metastatic Colon Cancer Patients: An Analysis Using the National Cancer Data Base. J Natl Cancer Inst 107(3), 2015. e-Pub 2015. PMID: 25663688.
190. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten-year institutional experience. J Surg Oncol 109(7):652-8, 2014. e-Pub 2014. PMID: 24510523.
191. Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer 120(8):1162-70, 2014. e-Pub 2014. PMID: 24474245.
192. Massarweh NN, Chiang YJ, Xing Y, Chang GJ, Haynes AB, You YN, Feig BW, Cormier JN. Association Between Travel Distance and Metastatic Disease at Diagnosis Among Patients With Colon Cancer. J Clin Oncol 32(9):942-8, 2014. e-Pub 2014. PMID: 24516014.
193. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys 88(2):301-5, 2014. e-Pub 2014. PMID: 24315563.
194. Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, Chang GJ, Dietz DW, Cancer (OSTRiCh) CFOTTOR. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg 260(4):625-31; discussion 631-2, 2014. e-Pub 2014. PMID: 25203879.
195. Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol 32(27):2967-74, 2014. e-Pub 2014. PMID: 25092785.
196. Eng C, Chang GJ, You YN, Das P, Rodriguez-Bigas M, Xing Y, Vauthey JN, Rogers JE, Ohinata A, Pathak P, Sethi S, Phillips JK, Crane CH, Wolff RA. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget 5(22):11133-42, 2014. e-Pub 2014. PMID: 25373735.
197. Abbas MA, Chang GJ, Read TE, Rothenberger DA, Garcia-Aguilar J, Peters W, Monson JR, Sharma A, Dietz DW, Madoff RD, Fleshman JW, Greene FL, Wexner SD, Remzi FH, Rectal Cancer CFOSTO. ConsoritumConsortium for Optimizing Surgical Treatment of Rectal Cancer. Optimizing rectal cancer management: analysis of current evidence. Dis Colon Rectum 57(2):252-9, 2014. e-Pub 2014. PMID: 24401889.
198. Phatak UR, Li LT, Karanjawala B, Chang GJ, Kao LS. Systematic review of educational interventions for ostomates. Dis Colon Rectum 57(4):529-37, 2014. e-Pub 2014. PMID: 24608311.
199. Lee S, Reha JL, Tzeng CW, Massarweh NN, Chang GJ, Hetz SP, Fleming JB, Lee JE, Katz MH. Race Does Not Impact Pancreatic Cancer Treatment and Survival in an Equal Access Federal Health Care System. Ann Surg Oncol 20(13):4073-9, 2013. e-Pub 2013. PMID: 24002535.
200. Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB. The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma. Ann Surg Oncol 20 Suppl 3(3 SUPPL):S500-8, 2013. e-Pub 2013. PMID: 23397153.
201. Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119(21):3769-75, 2013. e-Pub 2013. PMID: 24037775.
202. Bednarski, BK, Chang, GJ. Ultra-low anterior resection following neoadjuvant chemoradiation for rectal cancer. Seminars in Colon and Rectal Surgery 24(3):159-163, 2013. e-Pub 2013.
203. Badgwell B, Stanley J, Chang GJ, Katz MH, Lin HY, Ning J, Klimberg SV, Cormier JN. Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery. J Surg Oncol 108(3):182-6, 2013. e-Pub 2013. PMID: 23804149.
204. Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A Novel Risk-Adjusted Nomogram for Rectal Cancer Surgery Outcomes. JAMA Surg 148(8):1-9, 2013. e-Pub 2013. PMID: 23803722.
205. Collaborative BT. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):E1-E33, 2013. e-Pub 2013. PMID: 23754654.
206. Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal R, Mansfield P, Chang GJ. Improving the AJCC/TNM Staging for Adenocarcinomas of the Appendix: The Prognostic Impact of Histological Grade. Ann Surg 257(6):1072-8, 2013. e-Pub 2013. PMID: 23001080.
207. Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD, Rafferty J, Rectal Surgeons SPTFOTASOCA. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 56(5):535-50, 2013. e-Pub 2013. PMID: 23575392.
208. Hu CY, Xing Y, Cormier JN, Chang GJ. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer 119(10):1900-7, 2013. e-Pub 2013. PMID: 23408226.
209. Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum 56(5):551-9, 2013. e-Pub 2013. PMID: 23575393.
210. Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN. Neuroendocrine Tumors of the Colon and Rectum: Prognostic Relevance and Comparative Performance of Current Staging Systems. Ann Surg Oncol 20(4):1170-8, 2013. e-Pub 2013. PMID: 23212760.
211. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer 108(7):1508-14, 2013. e-Pub 2013. PMID: 23470470.
212. Mirnezami R, Chang GJ, Das P, Chandrakumaran K, Tekkis P, Darzi A, Mirnezami AH. Intraoperative radiotherapy in colorectal cancer: Systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol 22(1):22-35, 2013. e-Pub 2013. PMID: 23270946.
213. Greenberg CC, Wind JK, Chang GJ, Chen RC, Schrag D. Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium. J Comp Eff Res 2(2):117-25, 2013. e-Pub 2013. PMID: 24236554.
214. Hsu C, Rashid A, Xing Y, Chiang YJ, Chagpar RB, Fournier KF, Chang GJ, You YN, Feig BW, Cormier JN. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol 107(2):136-43, 2013. e-Pub 2013. PMID: 22767417.
215. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of Staged Proctectomy After Hepatectomy for Colorectal Cancer: A Matched Case-Control Analysis. Ann Surg Oncol 20(2):482-90, 2013. e-Pub 2013. PMID: 22932858.
216. Skinner HD, Crane CH, Garrett CR, Eng C, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Kelly P, Sandulache VC, Delclos ME, Krishnan S, Das P. Metformin use and improved response to therapy in rectal cancer. Cancer Med 2(1):99-107, 2013. e-Pub 2013. PMID: 24133632.
217. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Feig B, Nguyen S, Hu CY, Chang GJ. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum 56(2):135-41, 2013. e-Pub 2013. PMID: 23303140.
218. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, Hu CY, Feig BW, You YN, Cormier JN. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer 119(8):1593-601, 2013. e-Pub 2013. PMID: 23280510.
219. Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231-41, 2013. e-Pub 2013. PMID: 24089344.
220. Phatak UR, Kao LS, You YN, Rodriguez-Bigas MA, Skibber JM, Feig BW, Nguyen S, Cantor SB, Chang GJ. Impact of Ileostomy-Related Complications on the Multidisciplinary Treatment of Rectal Cancer. Ann Surg Oncol 21(2):507-12, 2013. e-Pub 2013. PMID: 24085329.
221. You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA, Feig BW, Slack R, Nguyen S, Skibber JM. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum 55(12):1213-9, 2012. e-Pub 2012. PMID: 23135578.
222. Hyngstrom JR, Hu CY, Xing Y, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Cormier JN, Chang GJ. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol 19(9):2814-21, 2012. e-Pub 2012. PMID: 22476818.
223. Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD, Rectal Surgeons SPTFOTASOCA. Practice parameters for the management of colon cancer. Dis Colon Rectum 55(8):831-43, 2012. e-Pub 2012. PMID: 22810468.
224. Phatak UR, Pedroza C, Millas SG, Chang GJ, Lally KP, Kao LS. Revisiting the effectiveness of interventions to decrease surgical site infections in colorectal surgery: A Bayesian perspective. Surgery 152(2):202-11, 2012. e-Pub 2012. PMID: 22828141.
225. Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, Chang GJ. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215(2):262-70, 2012. e-Pub 2012. PMID: 22560316.
226. Steele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Buie WD, Rectal Surgeons SPTFOTASOCA. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 55(7):735-49, 2012. e-Pub 2012. PMID: 22706125.
227. Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J. Is the 1-cm Rule of Distal Bowel Resection Margin in Rectal Cancer Based on Clinical Evidence? A Systematic Review. Indian J Surg Oncol 3(2):139-46, 2012. e-Pub 2012. PMID: 23728157.
228. Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ. Clinical Calculator of Conditional Survival Estimates for Resected and Unresected Survivors of Pancreatic Cancer. Arch Surg 147(6):513-519, 2012. e-Pub 2012. PMID: 22351874.
229. Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 30(15):1770-6, 2012. e-Pub 2012. PMID: 22493423.
230. Overman MJ, Hu CY, Kopetz S, Abbruzzese JL, Wolff RA, Chang GJ. A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare Disease. Ann Surg Oncol 19(5):1439-45, 2012. e-Pub 2012. PMID: 22187121.
231. Chang GJ, You YN, Park IJ, Kaur H, Hu CY, Rodriguez-Bigas MA, Skibber JM, Ernst RD. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum 55(4):371-7, 2012. e-Pub 2012. PMID: 22426259.
232. Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J. Is the 1-cm Rule of Distal Bowel Resection Margin in Rectal Cancer Based on Clinical Evidence? A Systematic Review. Ann Surg Oncol 19(3):801-8, 2012. e-Pub 2012. PMID: 21879269.
233. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, Chang GJ, Skibber JM, Ernst RD. MR Imaging for Preoperative Evaluation of Primary Rectal Cancer: Practical Considerations. Radiographics 32(2):389-409, 2012. e-Pub 2012. PMID: 22411939.
234. Chagpar R, Xing Y, Chiang YJ, Feig BW, Chang GJ, You YN, Cormier JN. Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer. J Clin Oncol 30(9):972-9, 2012. e-Pub 2012. PMID: 22355049.
235. Park IJ, You YN, Schlette E, Nguyen S, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Reverse-hybrid robotic mesorectal excision for rectal cancer. Dis Colon Rectum 55(2):228-33, 2012. e-Pub 2012. PMID: 22228169.
236. You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset Colorectal Cancer: Is It Time to Pay Attention?. Arch Intern Med 172(3):287-9, 2012. e-Pub 2012. PMID: 22157065.
237. Russell MC, Chang GJ. Molecular Profiling for Stage II Colon Cancer. Colorect Cancer 1(6):479-490, 2012. e-Pub 2012.
238. Steele SR, Kumar R, Feingold DL, Rafferty JL, Buie WD, Rectal Surgeons SPTFOTASOCA. Practice parameters for the management of perianal abscess and fistula-in-ano. Dis Colon Rectum 54(12):1465-74, 2011. e-Pub 2011. PMID: 22067173.
239. Al-Refaie WB, Hu CY, Pisters PW, Chang GJ. Gastric Adenocarcinoma in Young Patients: a Population-Based Appraisal. Ann Surg Oncol 18(10):2800-7, 2011. e-Pub 2011. PMID: 21424881.
240. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117(16):3713-22, 2011. e-Pub 2011. PMID: 21328329.
241. Blanke CD, Goldberg RM, Grothey A, Mooney M, Roach N, Saltz LB, Welch JJ, Wood WA, Meropol NJ, NCI GI Steering Committee Colon Cancer Task Force NCI. KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice. Oncologist 16(8):1061-8, 2011. e-Pub 2011. PMID: 21737577.
242. You YN, Habiba H, Chang GJ, Rodriguez-bigas MA, Skibber JM. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 18(4):989-96, 2011. e-Pub 2011. PMID: 21132391.
243. Kwon DS, Chang GJ. The role of minimally invasive surgery and outcomes in colorectal cancer. Perm J 15(3):61-6, 2011. e-Pub 2011. PMID: 22058671.
244. Overman MJ, Hu CY, Wolff RA, Chang GJ. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer 116(23):5374-82, 2010. e-Pub 2010. PMID: 20715162.
245. Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer. Ann Surg Oncol 17(11):2863-9, 2010. e-Pub 2010. PMID: 20552409.
246. Perry WB, Dykes SL, Buie WD, Rafferty JF, Rectal Surgeons SPTFOTASOCA. Practice parameters for the management of anal fissures (3rd revision). Dis Colon Rectum 53(8):1110-5, 2010. e-Pub 2010. PMID: 20628272.
247. Bowles TL, Xing Y, Hu CY, Mungovan KS, Askew RL, Chang GJ, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Conditional survival estimates improve over 5 years for melanoma survivors with node positive disease. Ann Surg Oncol 17(8):2015-23, 2010. e-Pub 2010. PMID: 20369298.
248. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?. J Am Coll Surg 210(6):934-41, 2010. e-Pub 2010. PMID: 20510802.
249. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 77(1):60-5, 2010. e-Pub 2010. PMID: 19695792.
250. Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 116(9):2234-41, 2010. e-Pub 2010. PMID: 20187100.
251. Rao G, Chang GJ, Suk I, Gokaslan Z, Rhines LD. Midsacral amputation for en bloc resection of chordoma. Neurosurgery 66(3 Suppl Operative):41-4, 2010. e-Pub 2010. PMID: 20124926.
252. Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 76(3):824-30, 2010. e-Pub 2010. PMID: 19464823.
253. Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg 251(2):261-4, 2010. e-Pub 2010. PMID: 19864936.
254. Schmeler KM, Daniels MS, Soliman PT, Broaddus RR, Deavers MT, Vu TM, Chang GJ, Lu KH. Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome. Obstet Gynecol 115(2 Pt 2):432-4, 2010. e-Pub 2010. PMID: 20093870.
255. Augestad KM, Lindsetmo RO, Stulberg J, Reynolds H, Senagore A, Champagne B, Heriot AG, Leblanc F, Delaney CP, Group (IRCSG) IRCS. International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. World J Surg 34(11):2689-700, 2010. e-Pub 2010. PMID: 20703471.
256. Lee JH, Ross WA, Davila R, Chang GJ, Lin E, Dekovich A, Davila M. Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: clinical experience of a tertiary cancer center. Dig Dis Sci 55(12):3530-6, 2010. e-Pub 2010. PMID: 20721627.
257. Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102(6):401-9, 2010. e-Pub 2010. PMID: 20185801.
258. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer 115(23):5432-40, 2009. e-Pub 2009. PMID: 19673001.
259. Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol 27(35):5938-43, 2009. e-Pub 2009. PMID: 19805670.
260. Chang GJ, Gonzalez RJ, Skibber JM, Eng C, Das P, Rodriguez-Bigas MA. A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum 52(8):1375-80, 2009. e-Pub 2009. PMID: 19617747.
261. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy. J Clin Oncol 27(22):3677-83, 2009. e-Pub 2009. PMID: 19470929.
262. Badgwell B, Chang GJ, Rodriguez-Bigas MA, Smith K, Lupo PJ, Frankowski RF, Delclos G, Du XL, Cormier JN. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol 16(10):2752-8, 2009. e-Pub 2009. PMID: 19649556.
263. Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Delclos ME, Krishnan S, Crane CH, Das P. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys 74(3):818-23, 2009. e-Pub 2009. PMID: 19147305.
264. Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 26(32):5254-60, 2008. e-Pub 2008. PMID: 18854565.
265. Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 71(4):1175-80, 2008. e-Pub 2008. PMID: 18207667.
266. Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Ellis V, Cleary K, Chang GJ. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol 15(1):46-51, 2008. e-Pub 2008. PMID: 17985187.
267. Camp RE, Chang GJ. Pneumatosis cystoides intestinalis following systemic chemotherapy for squamous cell carcinoma of the tongue. Surgical Rounds 31(3):137-39, 2008. e-Pub 2008.
268. Badgwell B, Feig BW, Ross MI, Mansfield PF, Wen S, Chang GJ. Pneumoperitoneum in the Cancer Patient. Ann Surg Oncol 14(11):3141-7, 2007. e-Pub 2007. PMID: 17680315.
269. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Krishnan S, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. Gastrointest Cancer Res 1(2):44-8, 2007. e-Pub 2007. PMID: 19262718.
270. Mullen JT, Rodriguez-Bigas MA, Chang GJ, Barcenas CH, Crane CH, Skibber JM, Feig BW. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol 14(2)(2):478-83, 2007. e-Pub 2007. PMID: 17103253.
271. Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol 14(6):1870-7, 2007. e-Pub 2007. PMID: 17406945.
272. Chang GJ, Skibber JM, Rodriguez-Bigas MA, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: Systematic Review. J Nat Can Inst 99(6):433-41, 2007. e-Pub 2007. PMID: 17374833.
273. Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68(3)(3):794-800, 2007. e-Pub 2007. PMID: 17379452.
274. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109(9)(9):1750-5, 2007. e-Pub 2007. PMID: 17387743.
275. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg 246(2)(2):215-21, 2007. e-Pub 2007. PMID: 17667499.
276. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 66(5)(5):1378-83, 2006. e-Pub 2006. PMID: 17056196.
277. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66(3)(3):762-71, 2006. e-Pub 2006. PMID: 17011451.
278. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29(3)(3):219-24, 2006. e-Pub 2006. PMID: 16755173.
279. Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States?. Am J Transplant 3(10)(10):1259-63, 2003. e-Pub 2003. PMID: 14510699.
280. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 45(4)(4):453-8, 2002. e-Pub 2002. PMID: 12006924.
281. Chang GJ, Liu T, Feng S, Bedolli M, O'Rourke R W, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery 132(2)(2):149-56, 2002. e-Pub 2002. PMID: 12219005.
282. Mahanty HD, Cherikh WS, Chang GJ, Baxter-Lowe LA Roberts JP. Influence of pretransplant pregnancy on survival of renal allografts from living donors. Transplantation 72(2):228-32, 2001. e-Pub 2001.
283. Jung SI, Chang GJ, Corbascio M, Potts M, Bedolli M, Ascher NI, Freise CF. Expression of intercellular adhesion molecule-1 in the cortex of preserved rat kidneys. J Surg Res 100(1)(1):69-75, 2001. e-Pub 2001. PMID: 11516207.
284. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant 14(6)(6):550-4, 2000. e-Pub 2000. PMID: 11127307.
285. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl 6(6)(6):734-40, 2000. e-Pub 2000. PMID: 11084060.
286. Berber E, Engle KL, String A, Garland AM, Chang GJ, Macho J, Pearl JM, Siperstein AE. Selective use of tube cholecystostomy with interval laparoscopic cholecystectomy in acute cholecystitis. Arch Surg 135:341-346, 2000. e-Pub 2000.
287. Chang GJ, Woo P, Honda HM, Ignarro LJ, Young L, Berliner JA, Demer LL. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen. Arterioscler Thromb 14(11):1808-14, 1994. e-Pub 1994. PMID: 7947607.
288. Keeney S, Chang GJ, Linn S. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J Biol Chem 268(28)(28):21293-300, 1993. e-Pub 1993. PMID: 8407967.

Invited Articles

1. Moon J, Maghanoy E, Higbie VS, Smith GL, Harrison D, White MG, Guraieb-Trueba M, Behman R, Smith PM, Messick CA, Bednarski BK, Konishi T, Rodriguez-Bigas MA, Chang GJ, Smith JJ, You YN. Impact of Dedicated Care Coordination on Access to Multidimensional Support Services in Young-Onset Colorectal Cancer: A Pragmatic Trial. JCO Oncol Pract:OP2600434, 2026. e-Pub 2026. PMID: 42218659.
2. Miyakawa T, Ochiai K, Guraieb-Trueba M, Ramamurthy J, Behman R, Messick CA, Nguyen S, Konishi T, Chang GJ. Comparison of surgical outcomes of robotic complete mesocolic excision for right-sided colon cancer in obese versus non-obese patients. Surg Endosc, 2026. e-Pub 2026. PMID: 41741794.
3. Conti, RM, McCue, S, Dockter, T, Gunn, HJ, Dusetzina, SB, Bennett, AV, Rapkin, B, Gracia, G, Jazowski, SA, Behrens, RJ, Richardson, PG, Chow, SL, Subbiah, N, Neuman, HB, Chang, GJ, Weiss, E. Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD). BMJ open 15(6), 2025. e-Pub 2025. PMID: 40461152.
4. Wolfson, JA, Grimes, AC, Nuno, M, Ramakrishnan, S, Dickens, DS, Roth, M, Woods, W, Adams, KS, Alabi, T, Beauchemin, M, Levine, J, Scialla, M, Boayue, KB, Kerber, CL, Ponce, O, Vargas, SL, Chang, GJ, Stock, W, Hershman, D, Curran, E, Advani, A, O'Dwyer, KM, Luger, SM, Liu, JJ, Freyer, DR, Sung, L, Parsons, SK. Guideline-concordant treatment among adolescents and young adults with acute lymphoblastic leukemia. JNCI Cancer Spectrum 9(3), 2025. e-Pub 2025. PMID: 40238217.
5. Bhutiani N, Yousef MM, Yousef AM, Haque EU, Chang GJ, Konishi T, Bednarski BK, You YN, Shen JP, Uppal A. Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer?. Clin Colorectal Cancer 24(2):272-279.e2, 2025. e-Pub 2025. PMID: 40038019.
6. Morris VK, Xiao W, Lin K, Wong CW, Wotman MT, Holliday EB, Huey RW, Noticewala SS, Ludmir EB, Bent AH, Ludford K, Messick C, Koay EJ, Smith G, Konishi T, Bednarski B, Chang GJ, Koong AC, You YN, Das P, Gillison ML. Time dependency for human papillomavirus circulating tumor DNA detection after chemoradiation as a prognostic biomarker for localized anal cancer. Clin Cancer Res 31(12):2399-2405, 2025. e-Pub 2025. PMID: 39873618.
7. Morris V, Xiao W, Lin K, Wong CW, Holliday E, Huey R, Noticewala S, Ludmir E, Bent A, Ludford K, Messick C, Koay E, Smith G, Konishi T, Bednarski B, Chang GJ, Koong A, You YN, Das P, Gillison M. The dependency for HPV ctDNA detection after chemoradiation as a prognostic biomarker for localized anal cancer. Clin Cancer Res. e-Pub 2024.
8. Ochiai, K, Bhutiani, N, Ikeda, A, Uppal, A, White, MG, Peacock, O, Messick, C, Bednarski, BK, You, YN, Skibber, JM, Chang, GJ, Konishi, T. Total Neoadjuvant Therapy for Rectal Cancer. Cancers 16(11), 2024. e-Pub 2024. PMID: 38893212.
9. Brydges, GJ, Chang, GJ, Gan, TJ, Konishi, T, Gottumukkala, V, Uppal, A. Testing Machine Learning Models to Predict Postoperative Ileus after Colorectal Surgery. Current Oncology 31(6):3563-3578, 2024. e-Pub 2024. PMID: 38920745.
10. Awiwi, M, Bhutani, N, Bednarski, BK, Konishi, T, Morani, A, Chang, GJ, Kaur, H. Miscategorized lymph nodes in colorectal cancer. Surgical Oncology Insight 1(1), 2024. e-Pub 2024.
11. Chang GJ. Better Selection for Preoperative Treatment in Rectal Cancer. J Am Coll Surg 231(4):425-426, 2020. e-Pub 2020. PMID: 32958137.
12. Greenberg C, Chang GJ, Nelson H. Patient-centered outcomes research: is this really something new?. Bull Am Coll Surg 99(1):51-2, 2014. e-Pub 2014. PMID: 24552033.
13. Bednarski BK, Chang GJ. Ultra-low anterior resection following neoadjuvant chemoradiation for rectal cancer: The end of the 1-cm rule?. Seminars in Colon and Rectal Surgery 24(3):159-163, 2013. e-Pub 2013.
14. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am 19(4):847-59, 2010. e-Pub 2010. PMID: 20883958.
15. Mortenson, MM, Chang, GJ. Lymph node sampling for rectal cancer. Current Colorectal Cancer Reports 4(4):211-217, 2008. e-Pub 2008.
16. Badgwell, BD, Chang, GJ. Lymph Node Evaluation and Survival in Stage II and III Colon Cancer. Seminars in Colon and Rectal Surgery 19(1):26-29, 2008. e-Pub 2008.
17. Fleshner, PR, Chalasani, S, Chang, GJ, Levien, DH, Hyman, NH, Buie, WD, Bastawrous, A, Sigurdson, E, Kumar, R, Steele, S, Newstead, R, Strong, S, Phang, T, Tjandra, J, Shellito, PC. Practice parameters for anal squamous neoplasms. Diseases of the colon and rectum 51(1):2-9, 2008. e-Pub 2008. PMID: 18030528.
18. Badgwell B, Chang GJ. Lymph node evaluation and survival in stage II and III colon cancer. Sem Col Rec Surg 19(1):26-9, 2008. e-Pub 2008.
19. Anaya DA, Chang GJ, Rodriguez-Bigas MA. Extracolonic manifestations of hereditary colorectal cancer syndromes. Clinics in Colon and Rectal Surgery 21(4):263-72, 2008. e-Pub 2008.
20. Mortenson M, Chang GJ. Lymph node sampling for rectal cancer: How much is enough?. Current Colorectal Cancer Reports 4(4):211-17, 2008. e-Pub 2008.
21. Badgwell, BD, Chang, GJ. Evidence for improved survival with increased lymph node evaluation in stage II and III colon cancer. American Journal of Oncology Review 6(11):631-633, 2007. e-Pub 2007.
22. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Barriers to rehabilitation of colorectal cancer patients. J Surg Oncol 95(5):400-8, 2007. e-Pub 2007. PMID: 17345598.
23. Badgwell B, Chang GJ. Evidence for improved survival with increased lymph node evaluation in stage II and III colon cancer. Am J Hematol Oncol 6(11):631-33, 2007. e-Pub 2007.
24. Feig BW, Chang GJ. Sentinel node assessment in colorectal cancer: Potential advantages and obstacles. American Society of Clinical Oncology Educational Book, 2007. e-Pub 2007.
25. Chang GJ. Laparoscopic treatment of colorectal neoplasia. Curr Treat Options Gastroenterol 9(3):256-64, 2006. e-Pub 2006. PMID: 16901389.
26. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Surgical implications of colorectal cancer genetics. Surg Oncol Clin N Am 15(1):51-66, vi, 2006. e-Pub 2006. PMID: 16389150.
27. Chang GJ. Abdominoperineal resection for distal rectal cancer-For the future, look to the past. Am J Oncol Rev 5(5):282-84, 2006. e-Pub 2006.
28. Chang GJ, Nelson H. Laparoscopic colectomy. Curr Gastroenterol Rep 7(5):396-403, 2005. e-Pub 2005. PMID: 16168239.
29. Chang, GJ, Shelton, A. Epidemiology and natural history of anal HPV infection and ASIL and cancer in the general population. Seminars in Colon and Rectal Surgery 15(4 SPEC. ISS):210-214, 2004. e-Pub 2004.
30. Chang GJ, Welton ML. Human papillomavirus, condylomata acuminata, and anal neoplasia. Clin Colon Rectal Surg 17(4):221-30, 2004. e-Pub 2004. PMID: 20011263.
31. Chang GJ, Shelton A. Epidemiology and natural history of anal HPV infection, ASIL and cancer in the general population. Seminars in Colon and Rectal Surgery 15(4):210-14, 2004. e-Pub 2004.
32. Chang GJ, Nelson H. Minimally invasive surgery for colorectal cancer. Colorectal Cancer Index and Reviews 5(4):4-7, 2004. e-Pub 2004.
33. Chang, GJ, Welton, ML. Anal neoplasia. Seminars in Colon and Rectal Surgery 14(2):111-118, 2003. e-Pub 2003.
34. Chang GJ, Welton ML. Anal intraepithelial neoplasia. Seminars in Colon and Rectal Surgery 14(2):111-18, 2003. e-Pub 2003.
35. Chang, GJ, Welton, ML. Condylomata acuminata. Problems in General Surgery 18(3):55-64, 2001. e-Pub 2001.
36. Chang GJ, Welton ML. Condylomata acuminata. Problems in General Surgery 18(3):55-64, 2001. e-Pub 2001.
37. Berber, E, Engle, KL, String, A, Garland, AM, Chang, GJ, Macho, J, Pearl, JM, Siperstein, AE. Selective use of tube cholecystostomy with interval laparoscopic cholecystectomy in acute cholecystitis. Archives of Surgery 135(3):341-346, 2000. e-Pub 2000. PMID: 10722039.
38. Awiwi MO, Bhutani N, Bednarski BK, Konishi T, Morani AC, Chang GJ, Kaur H. Miscategorized lymph nodes in colorectal cancer: A potential pitfall of presurgical imaging. Surgical Oncology Insight.

Review Articles

1. Nagtegaal, ID, Washington, K, Brierley, JD, Chang, GJ, Goldberg, RM, Shi, Q, Kakar, S, Kaur, H. Tumor Deposits in Colorectal Cancer. Modern Pathology 39(1), 2026. e-Pub 2026. PMID: 41591951.
2. Uemura M, Watanabe J, Shiomi A, Akiyoshi T, Chang GJ, Kanemitsu Y, Takemasa I, Sakai Y, Watanabe M, Endo I. Surgical Procedure of Lateral Lymph Node Dissection for Advanced Lower Rectal Cancer. Ann Gastroenterol Surg 9(6):1112-1118, 2025. e-Pub 2025. PMID: 41199967.
3. Watanabe, J, Shiomi, A, Akiyoshi, T, Chang GJ, Kanemitsu, Y, Takemasa, I, Saki, Y, Watanabe, M, Endo, I. Surgical Procedure of Lateral Lymph Node Dissection for Advanced Lower Rectal Cancer. Ann Gastroenterol Surg, 2025. e-Pub 2025.
4. Benson, AB, Venook, AP, Adam, M, Chang, GJ, Chen, YJ, Ciombor, KK, Cohen, S, Cooper, HS, Deming, DA, Garrido-Laguna, I, Grem, JL, Haste, P, Hecht, JR, Hoffe, S, Hunt, S, Hussan, H, Johung, KL, Joseph, N, Kirilcuk, N, Krishnamurthi, SS, Malla, M, Maratt, JK, Messersmith, WA, Meyerhardt, JA, Miller, ED, Mulcahy, MF, Nurkin, S, Overman, MJ, Parikh, AR, Patel, H, Pedersen, KS, Saltz, L, Schneider, CJ, Shibata, D, Shogan, BD, Skibber, JM, Sofocleous, CT, Tavakkoli, A, Willet, CG, Wu, CS, Gurski, LA, Snedeker, J, Jones, F. Colon Cancer, Version 3.2024. JNCCN Journal of the National Comprehensive Cancer Network 22(2d), 2024. e-Pub 2024. PMID: 38862008.
5. Ochiai K, Bhutiani N, Ikeda A, Uppal A, White MG, Peacock O, Messick CA, Bednarski BK, You YN, Skibber JM, Chang GJ, Konishi T. Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use?. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893212.
6. Bhutiani N, Peacock O, Uppal A, You YN, Bednarski BK, Skibber JM, Messick C, White MG, Chang GJ, Konishi T. The current multidisciplinary management of rectal cancer. Ann Gastroenterol Surg 8(3):394-400, 2024. e-Pub 2024. PMID: 38707228.
7. West, CT, West, MA, Mirnezami, AH, Drami, I, Glyn, T, Sutton, PA, Tiernan, J, Behrenbruch, C, Guerra, GR, Waters, PS, Woodward, N, Applin, S, Charles, SJ, Rose, SA, Denys, A, Pape, E, van Ramshorst, GH, Baker, D, Bignall, E, Blair, I, Davis, P, Edwards, T, Jackson, K, Leendertse, PG, Love-Mott, E, MacKenzie, L, Martens, F, Meredith, D, Nettleton, SE, Trotman, MP, van Hecke, JJ, Weemaes, AM, Abecasis, N, Angenete, E, Aziz, O, Bacalbasa, N, Barton, D, Baseckas, G, Beggs, A, Brown, K, Buchwald, P, Burling, D, Burns, E, Caycedo-Marulanda, A, Chang, GJ, Coyne, PE, Croner, R, Flatmark, K, Bednarski, BK, Peacock, O. The Empty Pelvis Syndrome. British Journal of Surgery 111(3), 2024. e-Pub 2024. PMID: 38456677.
8. Rooney MK, Pasli M, Chang GJ, Das P, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Peacock O, Smith GL, Holliday EB. Patient-Reported Sexual Function, Bladder Function and Quality of Life for Patients with Low Rectal Cancers with or without a Permanent Ostomy. Cancers (Basel) 16(1), 2023. e-Pub 2023. PMID: 38201580.
9. Bednarski BK, Taggart M, Chang GJ. MDT-How it is important in rectal cancer. Abdom Radiol (NY) 48(9):2807-2813, 2023. e-Pub 2023. PMID: 37393382.
10. Zahrieh D, Hillman SL, Tan AD, Frank JL, Dockter T, Meyers BJ, Cherevko CL, Peil ES, McCue S, Kour O, Gunn HJ, Neuman HB, Chang GJ, Paskett ED, Mandrekar SJ, Dueck AC. Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience. Trials 23(1):645, 2022. e-Pub 2022. PMID: 35945621.
11. Kroon HM, Hoogervorst LA, Hanna-Rivero N, Traeger L, Dudi-Venkata NN, Bedrikovetski S, Kusters M, Chang GJ, Thomas ML, Sammour T. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer. Eur J Surg Oncol 48(7):1475-1482, 2022. e-Pub 2022. PMID: 35568607.
12. Shen C, Tannenbaum D, Horn R, Rogers J, Eng C, Zhou S, Johnson B, Kopetz S, Morris V, Overman M, Parseghian C, Chang GJ, Lopez-Olivo MA, Kanwal R, Ellis LM, Dasari A. Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review. JAMA Netw Open 5(5):e2213588, 2022. e-Pub 2022. PMID: 35608860.
13. Bhutiani N, Peacock O, Chang GJ. A practical framework for the targeted use of total neoadjuvant therapy for rectal cancer. Cancer 128(11):2064-2072, 2022. e-Pub 2022. PMID: 35377951.
14. Kelly, M, O’Sullivan, NJ, Fahy, M, Aalbers, AG, Abdul Aziz, N, Abecasis, N, Abraham-Nordling, M, Abu Saadeh, F, Akiyoshi, T, Alberda, W, Albert, M, Andric, M, Angeles, MA, Angenete, E, Antoniou, A, Auer, R, Austin, KK, Aytac, E, Aziz, O, Bacalbasa, N, Baker, RP, Bali, M, Baransi, S, Baseckas, G, Bebington, B, Bedford, M, Bednarski, BK, Beets, GL, Berg, PL, Bergzoll, C, Beynon, J, Biondo, S, Boyle, K, Bordeianou, L, Brecelj, E, Bremers, AB, Brunner, M, Buchwald, P, Bui, A, Burgess, A, Burger, JW, Burling, D, Burns, E, Campain, NJ, Carvalhal, S, Castro, L, Chang, GJ, Flatmark, K, Larsen, SG, Peacock, O. Contemporary Management of Locally Advanced and Recurrent Rectal Cancer. Cancers 14(5), 2022. e-Pub 2022. PMID: 35267469.
15. Kaur, H, Gabriel, H, Taggart, MW, Kang, H, Konishi, T, Rauch, GM, Krishnan, S, Chang, GJ. MRI staging in an evolving management paradigm for rectal cancer, from the ajr special series on cancer staging. American Journal of Roentgenology 217(6):1282-1293, 2021. e-Pub 2021. PMID: 33949877.
16. Park IJ, Chang GJ. Survival and Operative Outcomes After Salvage Surgery for Recurrent or Persistent Anal Cancer. Ann Coloproctol 36(6):361-373, 2020. e-Pub 2020. PMID: 33486907.
17. Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qauod T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Pre-Transplant Solid Organ Malignancy and Organ Transplant Candidacy: A Consensus Expert Opinion Statement. Am J Transplant 21(2):460-474, 2020. e-Pub 2020. PMID: 32969590.
18. Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Pre-Existing Melanoma and Hematological Malignancies, Prognosis and Timing to Solid Organ Transplantation: A Consensus Expert Opinion Statement. Am J Transplant 21(2):475-483, 2020. e-Pub 2020. PMID: 32976703.
19. Ren, L, Zhu, D, Benson, AB, Nordlinger, B, Koehne, CH, Delaney, CP, Kerr, D, Lenz, HJ, Fan, J, Wang, JP, Gu, J, Li, J, Shen, L, Tsarkov, PV, Tejpar, S, Shu, Z, Zhang, SZ, Gruenberger, T, Qin, X, Wang, X, Zhang, Z, Poston, G, Xu, J, Zhou, AP, Parvaiz, A, Zhu, A, Eng, C, Lau, Cw, Song, C, Tang, CN, Lynch, C, Wan, DS, Loyer, EM, Aucejo, F, Wang, F, Chang, GJ, Chen, G, Yang, Gz, Choi, GS, Wieshmann, H, Tulina, I, Oh, JH, Ngu, JC, Wang, JY, Zhou, J, Xu, R, Cai, S, Konishi, T, You, YN, Pan, Z. Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019). European Journal of Surgical Oncology 46(6):955-966, 2020. e-Pub 2020. PMID: 32147426.
20. Peacock O, Chang GJ. The Landmark Series: Management of Lateral Lymph Nodes in Locally Advanced Rectal Cancer. Ann Surg Oncol 27(8):2723-2731, 2020. e-Pub 2020. PMID: 32519144.
21. Collaborative P. Palliative pelvic exenteration: A systematic review of patient-centered outcomes. Eur J Surg Oncol 45(10):1787-1795, 2019. e-Pub 2019. PMID: 31255441.
22. Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, Rockall TA, Young-Fadok TM, Hill AG, Soop M, de Boer HD, Urman RD, Chang GJ, Fichera A, Kessler H, Grass F, Whang EE, Fawcett WJ, Carli F, Lobo DN, Rollins KE, Balfour A, Baldini G, Riedel B, Ljungqvist O. Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018. World J Surg 43(3):659-695, 2019. e-Pub 2019. PMID: 30426190.
23. Berian, JR, Cuddy, A, Francescatti, A, O’Dwyer, L, You, YN, Volk, R, Chang, GJ. A systematic review of patient perspectives on surveillance after colorectal cancer treatment. Journal of Cancer Survivorship 11(5):542-552, 2017. e-Pub 2017. PMID: 28639159.
24. Ikoma N, Raghav K, Chang GJ. An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma. Surg Oncol Clin N Am 26(4):667-687, 2017. e-Pub 2017. PMID: 28923224.
25. Massarweh NN, Artinyan A, Chang GJ. Neoadjuvant treatment for rectal cancer-A value-based proposition. J Surg Oncol 114(3):304-310, 2016. e-Pub 2016. PMID: 27111410.
26. Steele SR, Chang GJ, Hendren S, Weiser M, Irani J, Buie WD, Rafferty JF, Rectal Surgeons CPGCOTASOCA. Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. Dis Colon Rectum 58(8):713-25, 2015. e-Pub 2015. PMID: 26163950.
27. Bhangu, A, Beynon, J, Brown, G, Chang, GJ, Das, P, Desai, A, Frizelle, F, Glynne-Jones, R, Goldin, RD, Hawkins, M, Heriot, A, Laurberg, S, Mirnezami, AH, Moran, BJ, Nicholls, J, Sagar, P, Tekkis, P, Vuong, T, Wilson, M, Ali, S, Antoniou, A, Bose, P, Boyle, K, Branagan, G, Burling, D, Clark, S, Colquhoun, P, Crane, C, Darzi, A, Davies, M, Delaney, CP, Dietz, DW, Dozois, EJ, Duff, M, Dziki, A, Faria, J, Fitzgerald, JE, Georgiou, P, George, B, George, ML, Gupta, A, Guy, R, Harji, DP, Harris, DA, Herzig, D, Holm, T, Hompes, R, Jeys, L, Jenkins, JT, Kiran, RP, Koh, CE, Law, WL, Liberman, AS, Marshall, M, McArthur, DR, Mortensen, N, Myers, E, O'Connell, PR, O'Dwyer, ST, Oliver, A, Pallan, A, Patel, P, Patel, UB, Radley, S, Ramsey, KW, Rasmussen, PC, Richard, C, Rutten, H, Sebag-Montefiore, D, Solomon, MJ, Stocchi, L, Swallow, C, Tait, DM, Tan, E, Van As, NJ, Wiggers, T, de Wilt, JH, Winter, DC, Woodhouse, C. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. British Journal of Surgery 100(8):E1-E33, 2013. e-Pub 2013. PMID: 23901427.
28. Anaya, DA, Chang, GJ, Rodriguez-Bigas, MA. Extracolonic manifestations of hereditary colorectal cancer syndromes. Clinics in Colon and Rectal Surgery 21(4):263-272, 2008. e-Pub 2008. PMID: 20011437.
29. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang GJ, Pisters LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol 26(1):9-16, 2008. e-Pub 2008. PMID: 18190824.
30. Mahanty, HD, Cherikh, WS, Chang, GJ, Baxter-Lowe, LA, Roberts, JP. Influence of pretransplant pregnancy on survival, of renal allografts from living donors. Transplantation 72(2):228-232, 2001. e-Pub 2001. PMID: 11477343.

Professional Educational Materials

1. Benson AB, Venook AP, Adam M, Chang GJ, Chen Y, Ciombor KK, Cohen SA, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Haste P, Hecht J, Hoffe S, Hunt S, Hussan H, Johung KL, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber JM, Sofocleous CT, Tavakkoli A, Willett CG, Wu C, Gurski LA, Snedeker J, Jones F. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology, 2024.
2. Chang GJ. The ASCRS Manual of Colon and Rectal Surgery: Rectal Cancer: Watch and Wait. Springer Nature, 2019.
3. Chang G. Audio-Digest General Surgery Board Review: Multidisciplinary Treatment of Rectal Cancer. Audio-Digest Foundation, 2013.
4. Chang GJ. Update on multidisciplinary therapy for locally advanced rectal cancer, 2012.
5. Chang GJ. Molecular Profiling for Colon Cancer: PRO. American Society of Clinical Oncology Gastrointestinal Symposium Educational book, 2012.
6. Chang, GJ. Update on multidisciplinary therapy for locally advanced rectal cancer, 2010.
7. Chang GJ. Rectal Cancer Treatment Guidelines - Treatment Algorythm. MD Anderson Cancer Center, 2009.
8. Chang GJ. Colon Cancer Treatment Guidelines - Treatment Algorythm. MD Anderson Cancer Center, 2009.
9. Feig BW, Chang GJ. Sentinel Node Assessment in Colorectal Cancer: Potential Advantages and Obstacles." American Society of Clinical Oncology Educational Book, 2007.
10. Chang GJ. Issues in the treatment of colorectal cancer: Not for surgeons only. Highlights of the American Society of Colon and Rectal Surgeons (ASCRS) 2005 Annual Meeting, 2005.

Other Articles

1. Bello, RJ, Chang, GJ, Massarweh, NN Colorectal Cancer Screening in the US-Still Putting the Cart Before the Horse?. JAMA Oncology 8(7):971-972, 2022. PMID: 35511165.
2. Eng, C, Chang, GJ, You, YN Long-Term results of weekly/daily cisplatin-Based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Diseases of the colon and rectum 57(5):e66-e67, 2014. PMID: 24037775.

Editorials

1. Brown, K, Chang, GJ. ctDNA-based Molecular Residual Disease After Surgery for Rectal cancer - a Step Toward Personalized, biomarker-driven Treatment. Annals of surgery, 2025. PMID: 41159646.
2. Sammour, T, Peacock, O, Bednarski, BK, Dasari, NV, Das, P, Johnson, B, Smith, GL, Chang, GJ, Skibber, JM, You, YN. Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer. Colorectal Disease 27(5), 2025. PMID: 40371878.
3. Chang GJ, Herb JN, Snyder RA. Implementing Policy- and System-Level Interventions to Address Rural Health Disparities in Patients With Cancer. ASCO Daily News, 2024.
4. Guraieb-Trueba M, Chang GJ. Transanal vs Laparoscopic TME--all that Glitters is not Gold. Ann Surg 277(1):7-8, 2022. PMID: 35916131.
5. Kong JC, Lee J, Gosavi R, Ngan SY, Tillman MM, Bednarski BK, Heriot AG, Chang GJ, Warrier SK. Is Neoadjuvant Therapy an Alternative Strategy to Immediate Surgery in Locally Perforated Colon Cancer?. Colorectal Dis 23(12):3162-3172, 2021. PMID: 34379861.
6. Snyder RA, He J, Le-Rademacher J, Ou FS, Dodge AB, Zemla TJ, Paskett ED, Chang GJ, Innocenti F, Blanke C, Lenz HJ, Polite BN, Venook AP. Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931). Cancer 127(20):3801-3808, 2021. PMID: 34374082.
7. Kong JCH, Chang GJ. Apples and oranges: The evidence regarding lateral pelvic lymph node dissection for rectal cancer. Surgery 169(5):1003-1004, 2021. PMID: 33745734.
8. Chang GJ. Primary Tumor Resection in Colorectal Cancer With Synchronous Unresectable Metastasis: Time to End the Debate?. J Clin Oncol 39(10):JCO2100057, 2021. PMID: 33591837.
9. Peacock, O, Chang, GJ. Is the learning curve the Achilles heel of surgical innovation? -arguments against TaTME. Annals of Laparoscopic and Endoscopic Surgery 5(October), 2020.
10. Peacock O, Chang GJ. ASO Author Reflections: Superior Mesenteric Vein (SMV): First Approach for Complete Mesocolic Excision. Ann Surg Oncol 27(9):3501-3502, 2020. PMID: 32314155.
11. Chang GJ. Opinion: Chadwick Boseman’s death highlights the alarming rate of colon cancer in young, Black Americans. Houston Chronicle, 2020.
12. Bartlett DL, Howe JR, Chang GJ, Crago A, Hogg M, Karakousis G, Levine E, Maker A, Mamounas E, McGuire K, Merchant N, Shibata D, Sohn V, Solorzano C, Turaga K, White R, Yang A, Yoon S, Surgical Oncology SO. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann Surg Oncol 27(6):1717-1720, 2020. PMID: 32270420.
13. Snyder, Chang GJ. Insurance Status ss a Surrogate for Social Determinants of Health in Cancer Clinical Trials. JAMA Network Open, 2020. PMID: 32352526.
14. Snyder RA, Chang GJ. Insurance Status as a Surrogate for Social Determinants of Health in Cancer Clinical Trials. JAMA Netw Open 3(4):e203890, 2020. PMID: 32352526.
15. Miller ED, Ng K, Chang GJ. Expert Editorial: Personalizing Management of Limited mCRC: A Call for More Evidence. Gastrointestinal Cancers Symposium Daily News, 2020.
16. Schumacher JR, Neuman HB, Chang GJ, Kozower BD, Edge SB, Yu M, Vanness DJ, Si Y, Jacobs EA, Francescatti AB, Spears PA, Havlena J, Adesoye T, McKellar D, Winchester D, Burnside ES, Greenberg CC, Working Group AACBCS. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol 25(9):2587-2595, 2018. PMID: 29777402.
17. Chang GJ. Is there Validity in Propensity Score-Matched Estimates of Adjuvant Chemotherapy Effects for Patients with Rectal Cancer. JAMA Oncol 4(7):921-923, 2018. PMID: 29710090.
18. Chang GJ. Leveraging Data, the Next Big Advance for Quality Improvement in Colorectal Cancer. Dis Colon Rectum 61(4):415-416, 2018. PMID: 29521818.
19. Sammour T, Malakorn S, Bednarski BK, Kaur H, Shin US, Messick C, You YN, Chang GJ. Oncological Outcomes After Robotic Protectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg 267(3):521-526, 2018. PMID: 27997470.
20. Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum 61(1):77-83, 2018. PMID: 29215474.
21. Chang GJ, Gonen M. Prognostic and Predictive Ability of Tumor Sidedness: Another Vexing Difference Between Localized and Advanced Colon Cancer. JAMA Oncol 3(10):1314-1315, 2017. PMID: 28594984.
22. Chang GJ. Selective Lateral Pelvic Lymph Dissection for Rectal Cancer. Ann Surg Oncol 24(13):3797-3798, 2017. PMID: 28956307.
23. Chang GJ. Can prognostic scoring tools predict treatment outcomes. Dis Colon Rectum 60(9):875-876, 2017. PMID: 28796723.
24. Malakorn S, Chang GJ. Treatment of Rectal Cancer in the East and West: Should it be different?. Surgery 162(2):315-316, 2017. PMID: 28619666.
25. Sammour T, Chang GJ. Lateral Node Dissection in Low Rectal Cancer: Time for a Global Approach?. Ann Surg 266(2):208-209, 2017. PMID: 28437315.
26. Chang GJ. Treatment of locally advanced rectal cancer: turning good rationale into good evidence?. Dis Colon Rectum 60(7):649-650, 2017. PMID: 28594712.
27. Sandhu L, Chang GJ. Which Surgical Approach Is Best for Management of Rectal Cancer?: Does the End Point Tell How It Ends?. JAMA Surg 152(4):e165659, 2017. PMID: 28196188.
28. Chang GJ. Simulating Watch and Wait for Rectal Cancer. Dis Colon Rectum 58(2):155-6, 2015. PMID: 25585071.
29. Chang GJ, Kopetz S. Coordination of Care in Colon Cancer. Cancer 121(18):3201-3202, 2015. PMID: 26043269.
30. Chang GJ, Greenberg CC, Kozower BD, Boughey JC, Francescatti A, Mckellar DP, Winchester DP. NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance. Bull Am Coll Surg 99(8):57-8, 2014. PMID: 25145051.
31. Chang GJ. 'Watch-and-wait' for rectal cancer: what's the way forward?. Oncology (Williston Park) 28(7):617-8, 2014. PMID: 25144283.
32. Krishnan S, Chang GJ. Kras mutations and rectal cancer response to chemoradiation- are we closer to personalization of therapy?. Ann Surg Oncol 20(11):3359-62, 2013. PMID: 23864308.
33. Chang GJ. Emphasizing Surgery for Colon Cancer. Dis Colon Rectum 56(7):805-7, 2013. PMID: 23739185.
34. Chang GJ. Challenge of Primary Tumor Management in Patients with Stage IV Colorectal Cancer. J Clin Oncol 30(26):3165-6, 2012. PMID: 22869881.
35. Chang GJ. Primary tumor resection in stage IV colorectal cancer: the debate continues. Dis Colon Rectum 54(8):919-20, 2011. PMID: 21730777.
36. Badgwell, BD, Chang, GJ, Rodriguez-Bigas, MA, Smith, K, Lupo, PJ, Frankowski, RF, Delclos, G, Du, XL, Cormier, J. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol 53(7):1103, 2010.
37. Bedrosian I, Hu CY, Chang GJ. Response: Re: Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients. J Natl Cancer Inst 102(17):1372-73, 2010.
38. Chang GJ. Epidermal growth factor receptor expression discrepencies in metastatic colorectal cancer patients treated with cetuximab plus irinotecan-baed chemotherapy refractor to irinotecan and oxaliplatin. Dis Col Rec 52(6):1152-53, 2009.
39. Chang GJ, Lambert LA. The hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin. Ann Surg Onc 15(11):2993-5, 2008. PMID: 18787903.
40. Chang, GJ. Abdominoperineal resection for distal rectal cancer - For the future, look to the past. American Journal of Oncology Review 5(5):282-284, 2006.
41. Chang GJ. Abdominoperineal resection for distal rectal cancer - for the future, look to the past. Am J Oncol Rev 5(5):282-84, 2006.

Abstracts

1. Uppal, A, Bhutiani, N, Shen, JY, Alfaro, KD, Kell, R, Yousef, M, Yousef, A, Konishi, T, Holliday, EB, Morris, VK, Dasari, NV, Willis, JA, Newhook, TE, Bednarski, BK, You, YN, Peacock, O, Messick, C, Das, P, Chang, GJ, Kopetz, S. Association of pathologic nodal status with minimal residual disease after neoadjuvant treatment and resection of locally advanced rectal cancer. Journal of Clinical Oncology 42:205, 2024. e-Pub 2024.
2. White, MG, Damania, A, Alshenaifi, J, Sahasrabhojane, P, Peacock, O, Losh, J, Wong, M, Berkova, Z, Nguyen, S, Chang, GJ, Wargo, J, Ajami, NJ, Kopetz, S, You, YN. Tumoral microbial and pathway alterations associated with young-onset rectal cancer and its response to therapy. Journal of Clinical Oncology 42(3):160, 2024. e-Pub 2024.
3. Bhutiani, N, Johnson, B, Kopetz, S, White, MG, Willis, JA, Morris, VK, Chang, GJ, Uppal, A. Immune checkpoint blockade combined with targeted therapies to provide disease control in mismatch repair-proficient colorectal cancer with peritoneal metastases. Journal of Clinical Oncology 42(3_suppl):133, 2024. e-Pub 2024.
4. White M, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Berkova Z, Nguyen ST, Chang GJ, Wargo JA, Ajami NJ, Kopetz S, Y Nancy You. Tumoral microbial and pathway alterations associated with young-onset rectal cancer and its response to therapy, 2024. e-Pub 2024.
5. Uppal A, Bhutiani N, YC Shen JP, Alfaro K, Kell RJ, Yousef MM, Yousef AM, Konishi T, Holliday E, Van K Morris II, Dasari A, Willis J, Newhook TE, Bednarski BK, Y Nancy You, Peacock O, Messick C, Das P, Chang GJ, Kopetz S. Association of pathologic nodal status with minimal residual disease after neoadjuvant treatment and resection of locally advanced rectal cancer, 2024. e-Pub 2024.
6. Finlayson E, Gunn H, Barber A, Lowenstein LM, Dohan DP, Broering JM, Dockter T, Tan AD, Dueck AC, Bailey L, Chow SL, Wills R, Jatoi Am Lee EK, Delacoix SE, Gills J, Mulligan C, Hayseen T, Chang GJ. Geriatric pre-surgical optimization in the NCORP (Alliance), 2023. e-Pub 2023.
7. Childers C, Manisundaram N, Hu CY, Tran Cao HS, Chang GJ. Association of the Robotic Approach With Delays in Surgery For Colon Cancer, 2023. e-Pub 2023.
8. Childers C, Manisundaram, Hu CY, Chang GJ. Does Submitting A Modifier 22 Actually Work?, 2023. e-Pub 2023.
9. Manisundaram N, Hu CY, Uppal A, Peacock O, Bednarski BK, Konishi T, White M, You YN, Messick C, Tillman MM, Skibber JM, Das P, Smith GL, Holliday E, Dasari A, Johnson B, Morris VK, Chang GJ. Is There an Increase in Elective Utilization of Non-Operative Management for Rectal Cancer?, 2023. e-Pub 2023.
10. Chang GJ, Gunn H, Barger A, Lowenstein LM, Dohan DP, Broering JM, Dockter T, Tan AD, Dueck AC, Bailey L, Chow SL, Cleary RK, Mesleh M, Woodall C, Solfelt ML, Finlayson E. Surgical care and outcomes in older patients with cancer through implementation of a pre-surgical toolkit (OPTI-Surg): Interim results of a phase III cluster randomized trial (Alliance A231601CD), 2023. e-Pub 2023.
11. Fox DA, Konishi T, Kaur H, You YN, Raghav KP, Ge PS, Messick CA, Johnson B, Morris VK, Thomas JV, Shah P, Bednarski BK, Kopetz S, Chang GJ, Ludford K, Hibie V, Overman MJ, Bhamidipati D. Immunotherapy for localized MSI-H colorectal cancer: Characterizing endoscopic and imaging response, 2023. e-Pub 2023.
12. Dasari A, Bent AH, Alfaro-Munoz K, Huey RW, Johnson B, Lee MS, Morelli MP, Morris VK, Overman MJ, Parseghian CM, Raghav KPS, Shen J, Willis J, Newhook TE, Uppal A, You YN, Konishi T Chang GJ, Kopetz S, Wolff RA. Association of positive ctDNA-based minimal residual disease assays during surveillance and undiagnosed concomitant radiographic recurrences in colorectal cancer (CRC): Results from the MD Anderson INTERCEPT program, 2023. e-Pub 2023.
13. Corrigan KL, Holliday E, Guraieb-Trueba M, Peacock O, Skibber JM, Bednarski BK, Messick C, Tillman MM, Johnson B, Smith GL, Nguyen ST, Kundu S, Reinhardt A, Chang GJ Das P, You YN. A prospective evaluation of pelvic radiation vs. no radiation among patients with young-onset rectal cancer: Impact on patient-reported outcomes, 2023. e-Pub 2023.
14. Manisundaram N, Snyder RA, Hu CY, DiBrito SR, Chang GJ. Racial Disparities in Cancer Mortality in Patients with Gastrointestinal Malignancies Following Medicaid Expansion, 2023. e-Pub 2023.
15. Janak A, Peacock O, White M, Guraieb-Trueba M, Nguyen ST, Alshenaifi J, Kopetz S, Johnson B, Smith GL, Chang GJ, You YN. Internet-based assessment tools for predicting colorectal cancer risk: How do they communicate individualized risk to the young adult?, 2023. e-Pub 2023.
16. Uppal A, White M, Chang GJ, Zeineddine FA, Zeineddine MA, Abdelrahman MG, Scally C, Fournier K, Newhook TE, You YN, Willis J, Kopetz S, Shen JP. Tumor Mutations Associated with Outcomes in Colorectal Peritoneal Metastases, 2023. e-Pub 2023.
17. Janak A, Peacock O, White M, Guraieb-Trueba M, Nguyen ST, Alshenaifi J, Kopetz S, Johnson B, Smith GL, Chang GJ, You YN. Internet-based assessment tools for predicting colorectal cancer risk: How do they communicate individualized risk to the young adult?, 2023. e-Pub 2023.
18. Bhutiani N, Hu CY, Palis BE, Cotler J, Shi Q, Goldberg RM, Washington MK, Nelson H, Steele S, Chang GJ. Lack of hierarchical survival prognosis in AJCC staging for colon cancer: Implications for future summary stage classification, 2023. e-Pub 2023.
19. Agnes A, Peacock O, Manisundaram N, Konishi T, Bednarski B, Taggart M, Vikram R, Stanietzky N, You YN, Poster Presentaion CG. Evaluation of the learning-curve for robotic lateral pelvic lymph node dissection (LPLND) for the treatment of rectal cencer in a Western institution, 2022. e-Pub 2022.
20. Martin AN, Tzeng CW, Arvide EM Skibber JM, GJ &, You YN, Bednarski BK, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Cumulative operative time and postoperative complication risk in synchronous resection of colorectal liver metastases and primary tumors, 2022. e-Pub 2022.
21. Taku N, You YN, Ludmir EB, Smith GL, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Koong AC, Minsky BD, Holliday EB, Joay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Overman MJ, Kopez S, Raghav K, Das P. Clinical Outcomes Following Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer: A Single Institution Experience(suppl 15; abstr e15601), 2021. e-Pub 2021.
22. Conti RM, McCue S, Dockter T, Rapkin BD, Dusetzina S, Bennett AV, Garcia G, Johnson ME, Martin SA, Chang GJ, Richardson PG, Behrens RJ, Weiss ES. Assessing Financial Difficulty In Patients With Multiple Myeloma: Preliminary Results of ALLIANCE A231602CD(suppl 15; abstr 8031), 2021. e-Pub 2021.
23. You YN, Rodriguez-Bigas MA, Chang GJ, Bednarski BK, Skibber JM, Mork ME, Moskowitz JB, Nguyen ST, Thirumurthi S, Lynch PM, Kopetz S, Vilar Sanchez E. Are Current Family-history Based Colorectal Cancer Screening Guidelines Adequate For Early Detection And Potential Prevention Of Young-Onset Cases?(suppl 15; abstr 3549), 2021. e-Pub 2021.
24. Swords DS, Tran Cao HS, Bednarski BK, Vauthey JN, Chang GJ, You YN. Treatment Disparities Partially Mediate Diminished Survival in Disadvantaged Black and White Patients with Stage IV Colorectal Cancer (CRC), 2021. e-Pub 2021.
25. Zafar S, Hu C, Helmink B, Scally CP, Bednarski BK, Fournier KF, Chang GJ. Peritoneal Recurrence after Resection for Stage 1-3 Colorectal Cancer-A Popular Analysis, 2020. e-Pub 2020.
26. Peacock O, Yun Y, Thirmurthi S, Nguyen S, Lim P, Rodriguez-bigas MA, Bednarski BK, Messick CA, Skibber JM, Chang GJ, Vilar E, You YN. Metachronous colorectal pathology among survivors of young-onset colorectal cancer: Implications for postresection colonoscopic surveillance, 2020. e-Pub 2020.
27. Tilburt JC, Pacyna JE, Petereit DG, Kaur JS, Rapkin BD, Grubb R, Chang GJ, Morris MJ, Kovac E, Sloa JA, Basch EM, Storrick EM, Zahrieh D, Dueck AC, Paskett ED, Buckner JC, Montori V, Frosch DL, Volk RJ, Kim SP. Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol - A191402CD - A Cluster-Randomized Trial, 2020. e-Pub 2020.
28. Schrag D, Shi Q, Gollub MJ, Saltz LB, Chang GJ, Basch EM, Kolevska T, Gordon VL, Venook AP, O'Reilly EM, Meyerhardt JA, Mamon HJ. Selective versus standard use of neoadjuvant chemoradiation for locally advanced cancers prior to total mesorectal excision: surgical endpoints from the PROSPECT trial/N1048, 2020. e-Pub 2020.
29. Zafar S, Hu C, Snyder RA, Cuddy A, You YN, Lowenstein LM, Volk RJ, Chang GJ. Predicting Risk of Recurrence after Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study, 2019. e-Pub 2019.
30. Yang Y, Malakorn S, Zafar SN, Sandhu L, Chang GJ. Robotic Complete Mesocolic Excision for Right Colectomy in a High-BMI Patient: "SMV-first" Approach, 2019. e-Pub 2019.
31. Malakorn S, Bednarski BK, You YN, Chang GJ. Tumor Sidedness, Recurrence and Survival Another Important Difference Between Localized Colon Cancer, 2019. e-Pub 2019.
32. Healy M, Bednarski BK, Eng C, Das M, Rodriguez-Bigas MA, Skibber JM, Kaur H, Ernst R, Chang GJ, You YN. Higher Propensity for Nodal Metastases Among Young-Onset Rectal Cancers, 2019. e-Pub 2019.
33. Sandhu L, Romero M, Weldon M, You YN, Bednarski BK, Chang GJ. Is Extended VTE Prophylaxis After Minimally Invasive Surgery for Colorectal Cancer Justified? Results of a Systematic Literature Review, 2018. e-Pub 2018.
34. Chai CY, Chang GJ, Tran Cao H, Awad SS, Kimbrough BA, Artinyan A, Krishnan B, Massarweh NN. Management of Early Stage Squamous Cell Carcinoma of Anal Canal - Is Doing Less More, 2018. e-Pub 2018.
35. Sammour T, Malakorm S, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Eng C, Das P, Skibber JM, You YN. Longitudinal Trajectory of Cancer Survivorship in Patients with Recurrent Rectal Cancer: Anatomy of Recurrence Impacts Quality of Life and Pain, 2017. e-Pub 2017.
36. Adesoye T, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, Van Loon K, Schrag D, McKellar DP, Winchester DP, Chang GJ. Impact of Adjuvant Chemotherapy on Recurrence Risk in Stage II Colon Cancer, 2017. e-Pub 2017.
37. Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick C, Taggart M, Chang GJ, You YN. Minimally Invasive Complete Mesocolic Excision and Central Vascualr Ligation: Defining the Radicality of Central Lymphadenectomy for Right Colon Cancer, 2017. e-Pub 2017.
38. Sammour T, Malakorm S, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Eng C, Das P, Skibber JM, You YN. Longitudinal Trajectory of Cancer Survivorship in Patients with Recurrent Rectal Cancer: Anatomy of Recurrence Impacts Quality of Life and Pain, 2017. e-Pub 2017.
39. Adesoye T, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, Van Loon K, Schrag D, McKellar DP, Winchester DP, Chang GJ. Impact of Adjuvant Chemotherapy on Recurrence Risk in Stage II Colon Cancer, 2017. e-Pub 2017.
40. Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick C, Taggart M, Chang GJ, You YN. Minimally Invasive Complete Mesocolic Excision and Central Vascualr Ligation: Defining the Radicality of Central Lymphadenectomy for Right Colon Cancer, 2017. e-Pub 2017.
41. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, Schrag D, McKellar D, Winchester D, Kozower B, Greenberg CC, Chang GJ. Intensity of Post-Treatment Surveillance Does Not Impact Survival in Colorectal Cancer, 2017. e-Pub 2017.
42. Schumacher JR, Neuman HB, Zhang Y, Yu M, Vanness DJ, Si Y, Burnside ES, Ruddy KJ, Partridge AH, Schrag D, Edge SB, Jacobs EA, Havlena J, Francescatti AB, Winchester DP, McKellar DP, Spears PA, Chang GJ, Kozower BD, Greenberg CC. Asymptomatic distant recurrence detection and survival in early stage breast cancer: A nationally representative study, 2017. e-Pub 2017.
43. Cuddy A, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Messick CA, Nguyen S, You YN. Primary Health Concerns Perceived by Long-Term Disease-Free Colorectal Cancer Survivors, 2016. e-Pub 2016.
44. Lowenstein LM, Hempstead AP, Richards VF, Van Loon K, You YN, Volk RJ, Chang GJ. Patient Self-Advocacy in Decision Making Related to Post-Treatment Surveillance for Colorectal Cancer, 2016. e-Pub 2016.
45. Kaplan JA, Brinson Z, Hofer R, O'Sullivan P, Chang A, Horvath H, Chang GJ, Finlayson E. Early Learners as Health Coaches for Older Adults Preparing for Surgery. J Surg Res 209:184-190, 2016. e-Pub 2016. PMID: 28032558.
46. Patel SH, Chang GJ, Cuddy A, Mork ME, Bannon SA, Egger ME, Holder A, Bednarski BK, Skibber JM, Vilar-Sanchez E, Lynch PM, Rodriguez-Bigas MA, You YN. Decision for Non-Completion of Follow-Up Among Patients with Abnormal Screening Test for Heredity Colorectal Cancer Syndrome, 2016. e-Pub 2016.
47. You YN, Chang GJ, Bailey CE, Tran Cao HS, Cuddy A, Bednarski B, Feig BW, Nguyen S, Rodriguez-Bigas MA, Skibber JM. Risks and Distribution of Secondary Cancers Among Long-Term Survivors of Colon and Rectal Cancer, 2016. e-Pub 2016.
48. Cuddy A, Hu CY, Snyder RA, Francescatti AB, Schumacher JR, You YN, McKellar D, Wnchester DP, Chang GJ. Variation in Colorectal Cancer (CRC) Post-Treatment Surveillance Intensity (SI) and Detection of Recurrence. J Clin Oncol 34(suppl; abstr 6579), 2016. e-Pub 2016.
49. Cuddy A, Van Loon K, You YN, Hu CY, Francescatti AB, Greenberg CC, Venook AP, Schrag D, Chang GJ. How Clinicians Make Decisions Regarding Surveillance and Treatment of Colorectal Cancer (CRC) Patients. J. Clin Oncol 34(suppl 3S; abstr 263), 2016. e-Pub 2016.
50. Van Loon K, Hu CY, Cuddy A, Bekaii-Saab TS, Benson AB, Hall MJ, Lai LL, Nurkin SJ, Skibber JM, Weiser MR, Schrag D, Chang GJ. How are Colorectal Cancer (CRC) Patients Treated Following Cancer Recurrence During Follow-Up?. J. Clin Oncol 34(suppl 4S; abstr 645), 2016. e-Pub 2016.
51. Shin US, You YN, Price BA, Rodriguez-Bigas MA, Skibber JM, Maru DM, Taggart MW, Kopez S, Eng C, Minsky BD, Das P, Krishnan S, Chang GJ. Is the Neutrophil-Lymphocyte Ratio (NLR) a Predictive and Prognostic Factor in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiation (nCRT)?. J Clin Oncol 34(suppl;abstr 3605), 2016. e-Pub 2016.
52. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, You YN, McKellar D, Winchester DP, Chang GJ. Detection and Treatment of Colorectal Cancer (CRC) Recurrence During Routine Surveillance: A Nationwide Cohort Study 34(suppl; abstr e18137), 2016. e-Pub 2016.
53. Lowenstein LM, Cuddy A, Hempstead AP, Richards V, You YN, Volk RJ, Chang GJ. Patient's Knowledge of Colorectal Cancer Surveillance and Recurrence: A Qualitative Study, 2016. e-Pub 2016.
54. Van Loon K, Hu CY, Cuddy A, Bekaii-Saab T, Benson AB, Hall MJ, Lai L, Nurkin S, Skibber JM, Weiser MR, Schrag D, Chang GJ. How are Colorectal Cancer Patients Treated Following Cancer Recurrence During Follow-up?, 2016. e-Pub 2016.
55. Bailey CE, Hu CY, You YN, Cuddy A, Liles JS, Chang GJ. Definitive Surgical Salvage for Recurrent Colon Cancer. J Clin Oncol 33(suppl;abstr e14704), 2015. e-Pub 2015.
56. Lee MS, Clarke C, Jiang ZQ, Manyam GC, Tian F, Lu Y, Morris J, Broom BM, Menter D, Vilar Sanchez E, Shureiqi I, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Mills GB, Overman MJ, Maru DM, Kopetz S. Proteomic Signatures of Colorectal Cancer to Identify Distinct and Reproducible Subgroup and to Refelect Prognosis. J Clin Oncol 33(suppl;abstr 3612), 2015. e-Pub 2015.
57. Clarke C, Lee MS, Manyam GC, Jiang ZQ, Feng T, Lu Y, Morris J, Broom BM, Menter D, Vialr Sanchez E, Raghav K, Eng C, Chang GJ, Overman MJ, Maru DM, Kopetz S. Proteomic Features of Colorectal Cancer Independently Predict Relapse-Free Survival. J Clin Oncol 33(suppl 3; abstr 616), 2015. e-Pub 2015.
58. Lee MS, Clarke C, Jiang ZQ, Manyam GC, Tian F, Lu Y, Morris J, Broom BM, Menter D, Vialr Sanchez E, Shureiqi I, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Mills GB, Overman MJ, Maru DM, Kopetz S. Proteomic Signatures of Colorectal Cancer to Identify Distinct and Reproducible Subgroups Independent of Oncogenic Mutations. J Clin Oncol 33(suppl 3; abstr 580), 2015. e-Pub 2015.
59. Bailey CE, Hu CY, Cuddy A, You YN, Chang GJ. Surveillance Imaging Following Colon Cancer Resection: Universal or Risk-Based?, 2015. e-Pub 2015.
60. Salazar R, Capdevila J, Rosenberg R, Willem de Waard J, Glimelius B, Bibeau F, Klaase J, Van der Hoeven JJM, Midgley RA, Chang GJ, Bachleitner-Hofmann T, Asano M, Ziebermayr R, Levine EA, Deck KB, Sington J, Law WL, Shbeeb I, Stork L, Marshall J. Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial. J Clin Oncol 32:5s(suppl; abstract 3562), 2014. e-Pub 2014.
61. Bailey CE, Hu CY, You YN, Bednarski B, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Disparities in age-related incidence of colon and rectal cancer in the United States, 1975-2010. J Clin Oncol 32:5s(suppl; abstract 6579), 2014. e-Pub 2014.
62. Zheng Z, Jemal A, Lin CC, Chang GJ. Comparative effectiveness of laparoscopy versus open colectomy among nonmetastatic colon cancer patients: An analysis using the National Cancer Data Base. J Clin Oncol 32:5s(suppl; abstract 3627), 2014. e-Pub 2014.
63. Bailey CE, Hu CY, You YN, Chang GJ. Increasing disparities in age-related incidence of colon and rectal cancer in the United States, 1975-2010. J Clin Oncol 32(suppl 3; abstract 392), 2014. e-Pub 2014.
64. Morris VK, Rashid A, Rodriguez-Bigas MA, Das P, Wolff RA, Chang GJ, Crane CH, Phillips J, Ohinata A, Rogers J, Eng C. Association of human papillomavirus with unique clinicopathologic features in patients with metastatic squamous cell carcinoma of the anal canal 32(suppl 3; abstr 479), 2014. e-Pub 2014.
65. You YN, Bednarski BK, Chang GJ, Nguyen S, Cuddy A, Feig BW, Skibber JM, Rodriguez-Bigas MA. Defining Phenotypes and Pedigrees in Young onset Colorectal Cancer, 2013. e-Pub 2013.
66. Kopetz S, Jiang ZQ, Overman MJ, Dreezen C, Tian S, Li Y, Simon I, Chang GJ, Maru DM. Genomic classifiers (ColoPrint/MSI-Print) predict outcome and chemotherapy benefit in stage II and III colon cancer patients. J Clin Oncol 31(suppl 4; abstr 378), 2013. e-Pub 2013.
67. You YN, Sanchez EV, Slack R, Chang GJ, Nguyen ST, Cuddy A, Khose S, Wisniewski W, Bannon SA, Mork MA, Lynch PM, Rodriguez-Bigas MA. Lynch syndrome testing in ethnically diverse patients: Mutation spectrum and performance of prediction models. J Clin Oncol 31(suppl; abstr 1546), 2013. e-Pub 2013.
68. Chang GJ. Use of High Resolution MRI in Determining Tumor-Free Resection Margin in Rectal Cancer, 2013. e-Pub 2013.
69. Kopetz S, Jiang Z, Overman M, Rosenburg R, Salazar R, Tabernero J, Stork L, Li Y, Simon I, Chang GJ, Maru D. Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients J Clin Oncol 31(suppl; abstr 3612), 2013. e-Pub 2013.
70. Chang GJ, Park IJ, Eng C, You YN, Kopetz S, Overman MJ, Rodriguez-Bigas MA, Skibber JM. Exploratory analysis of adjuvant chemotherapy benefits after preoperative chemoradiotherapy and radical resection for rectal Cancer J Clin Oncol 30(suppl; abstr 3556), 2012. e-Pub 2012.
71. Eng C, Rogers J, Chang GJ, You YN, Das P, Rodriguez-Bigas MA, Ohinata A, Phillips J, Abbruzzese JL, Wolff RA. Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal J Clini Oncol 30(suppl; abstr 4060), 2012. e-Pub 2012.
72. Park IJ, You NY, Skibber JM, Rodriguez-Bigas MA, Feig BW, Nguyen ST, Chang GJ. Oral Presentation, Recurrence patterns after multidisciplinary therapy for rectal cancer in 725 patients, 2012. e-Pub 2012.
73. Russell MC, Chiang YJ, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind?, 2012. e-Pub 2012.
74. Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-caucasian patients, 2012. e-Pub 2012.
75. Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting herediatary nonpolyposis colorectal cancer syndrome (HNPCC) in colorectal cancer (CRC) patients: Optimal strategies at lower costs, 2012. e-Pub 2012.
76. Haynes A, Chiang YJ, Feig B, Xing Y, Chang GJ, You YN, Cormier J. Association between delays in adjuvant chemotherapy for stage II and III colon cancer and increased mortality, 2012. e-Pub 2012.
77. Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggert MW, Skibber JM, Feig BW, You YN. Oral Presentation, Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter?, 2012. e-Pub 2012.
78. Haynes AB, Chiang YS, Boland GM, Xing Y, Massarweh NN, Chang GJ, You YN, Feig BW, Cormier JN. Socioeconomic and clinical factors associated with delayed initiation of adjuvant chemotherapy for stage III colon cancer. J Clin Oncol 30(suppl 34; abstr 173), 2012. e-Pub 2012.
79. Chen ZY, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong DS, Hoff P, Tran HT, Heymach J, Overman MJ, Kopetz S. Correlation of specific cytokine profiles with high blood neutrophil-to-lymphocyte ratio and outcome in metastatic colorectal cancer. J Clin Oncol 30(suppl; abstr 3598), 2012. e-Pub 2012.
80. Salazar R, Marshall J, Capdevila J, Glimelius B, de Waard JW, Van Der Hoeven J, Klaase J, Bibeau F, Bachleitner-Hofmann T, Midgley RA, Levine EA, Law WL, Asano M, Chang GJ, Cohen SM, Beart RW, Goldfarb PM, McCarter M, Stork-Sloots L, Rosenberg R. The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint. J Clin Oncol 30(suppl; abstr TPS10632), 2012. e-Pub 2012.
81. Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-Caucasian patients. J Clin Oncol 30(suppl 4; abstr 417), 2012. e-Pub 2012.
82. Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggart MW, Skibber JM, Feig BW, You YN. Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter? J Clin Oncol 30(suppl 4; abstr 575), 2012. e-Pub 2012.
83. Haynes A, Chiang YJ, Feig B, Xing Y, Chang GJ, You YN, Cormier J. Association between delays in adjuvant chemotherapy for stage II and III colon cancer and increased mortality J Clin Oncol 30(suppl 4; abstr 541), 2012. e-Pub 2012.
84. Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in colorectal cancer (CRC) patients: Optimal strategies at lower costs J Clin Oncol 30(suppl 4; abstr 396), 2012. e-Pub 2012.
85. Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-Caucasian patients J Clin Oncol 30(suppl 4; abstr 417), 2012. e-Pub 2012.
86. Mitchell MP, Abboud M, Crane C, Eng C, Chang GJ, Rodriguez-Bigas MA, Skibber JM, You YN, Beddar S, Krishnan S, Delclos ME, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience J Clin Oncol 30(suppl 4; abstr 661), 2012. e-Pub 2012.
87. Overman MJ, Fournier KF, Hu CY, Wolff RA, Eng C, Taggart MW, Royal RE, Mansfield PF, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: The prognostic impact of histologic grade J Clin Oncol 30(suppl 4; abstr 402), 2012. e-Pub 2012.
88. Boland GM, Chiang Y, Chagpar R, Xing Y, Hu CY, Fieg BW, Chang GJ, You N, Cormier JN. Association of NCCN guideline adherence with improved survival in hihg-risk stage II and III colon cancer J Clin Oncol 30(suppl 4; abstr 543), 2012. e-Pub 2012.
89. Das P, Eng C, Rodriguez-Bigas, Chang GJ, Skibber JM, Maru D, Munsell MF, Clemons MV, Kopetz S, Garrett CR, Shureiqi I, Krishnan S, Delclos ME, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial J Clin Oncol(suppl 4; abstr 544), 2012. e-Pub 2012.
90. Tzeng CD, Chang GJ, Curley SA, Vauthey JN, Ellis LM, Skibber JM, Feig BW, Abdalla EK, Aloia TA, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis J Clin Oncol 30(suppl 4; abstr 629), 2012. e-Pub 2012.
91. Park IJ, Eng C, You YN, Kopetz S, Rodriguez-Bigas MA, Overman MJ, Skibber JM, Chang GJ. Exploratory analysis of adjuvant chemotherapy effects after preoperative chemoradiotherapy and radical resection for rectal cancer J Clin Oncol 30(suppl 4: abstr 557), 2012. e-Pub 2012.
92. Chang GJ, Hu CY, You YN, Eng C, Rodriguez-Bigas MA, Skibber JM. What determines adjuvant chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer? J Clin Oncol 30(suppl 4; abstr 546), 2012. e-Pub 2012.
93. Russell MC, Chiang Y, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind? J Clin Oncol 30(suppl 4; abstr 537), 2012. e-Pub 2012.
94. Bailey C, Hu C, You N, Rodriguez-Bigas M, Kaur H, Ernst R, Skibber M, Chang GJ. Population-based trends in position emission tomography (PET) utilization after resection for colon cancer J Clin Oncol 30(suppl; abstr 3556), 2012. e-Pub 2012.
95. Abbott DE, Aloia TA, Rodriguez-Bigas MA, Skibber JM, Feig BW, You NY, Curley SA, Vauthey JN, Chang GJ. Economic comparison of simultaneous and staged resection for synchronous metastatic colorectal cancer, 2011. e-Pub 2011.
96. Park, IJ, Chang GJ. Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer J Clin Oncol 29(suppl; abstr 3553), 2011. e-Pub 2011.
97. Chagpar R, Cormier JN, Feig BW, Chang GJ, You YN, Chiang M, Rodriguez-Bigas MA, Skibber JM, Xing Y. Adherence to NCCN treatment guidelines for rectal cancer: Analysis of national practice patterns J Clin Oncol 29(suppl; abstr 3554), 2011. e-Pub 2011.
98. Chang GJ, Park IJ, You YN, Hu C, Hamilton SR, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Nguyen ST, Rodriguez-Bigas MA, Skibber JM. Neoadjuvant treatment response and outcomes is locally advanced rectal cancer: Establishing oncologic benchmarks J Clin Oncol 29(suppl; abstr 3545), 2011. e-Pub 2011.
99. Chang GJ, You NY, Kaur H, Ernst RD. Can Pretreatment Rectal MRI Predict Response to Neoadjuvant Chemoradiation Therapy?, 2011. e-Pub 2011.
100. Chagpar R, Cormier JN, Xing Y, Chiang Y, Chang GJ, You YN, Rodriguez-Bigas MA, Skibber JM, Feig BW. Which stage II colon cancer patients are receiving recommendations for adjuvant chemotherapy? An analysis of current practices using the National Cancer Database, 2011. e-Pub 2011.
101. Chagpar R, Xing Y, Hsu C, Cormier JN, Rashid A, Chiang Y, Feig BW, Chang GJ, You, YN. Comparison and validation of three staging systems for neuroendocrine tumors of the colon and rectum, 2011. e-Pub 2011.
102. Jensen C, Ernst R, Chang GJ, You N, Hou P, Choi H, Rauch G, Kaur H. Preoperative MRI assessment of rectal cancer: Historical perspective to current trends, 2011. e-Pub 2011.
103. Park IJ, You YN, Schlette E, Nguyen S, Rodriguez-Bigas MA, Skibber JM, Chang GJ. The “Reverse” Hybrid Robotic Mesorectal Excision for Rectal Cancer, 2011. e-Pub 2011.
104. Hyngstrom JR, Hu C, Xing Y, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Cormier JM, Chang GJ. Clinicopathology and Outcomes with Mucinous and Signet Ring Colorectal Adenocarcinoma in the NCDB, 2011. e-Pub 2011.
105. Hsu C, Rashid A, Xing Y, Chiang Y, Chang GJ, You N, Feig B, Cormier J. Histologic subtypes of neuroendocrine tumors of the appendix have varying malignant potential, 2011. e-Pub 2011.
106. Chagpar R, Xing Y, You YN, Chiang Y, Feig BW, Chang GJ, Cormier JN. Predicting adherence to stage-specific treatment guidelines for adenocarcinoma of the colon, 2011. e-Pub 2011.
107. You Y, Xing Y, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ, Ling YK, Cormier JN. Risk factors for colorectal cancer in patients younger than 50, 2011. e-Pub 2011.
108. Hu C, Xing Y, Cormier JN, Chang GJ. The validity of cancer specific mortality within the surveillence, epidemiology, and end results registry, 2011. e-Pub 2011.
109. Jiang Z, Mehta TR, You YN, Chang GJ, Eng C, Overman JM, Maru D, Hamilton SR, Kopetz S. Association of PTEN loss and local recurrence in stage II-III colon cancer J Clin Oncol 29(suppl; abstr 399), 2011. e-Pub 2011.
110. Eng C, Xing Y, You YN, Chang GJ, Das P, Phillips J, Wolff RA, Rodriguez-Bigas AM, Ohinata A, Crane CH. Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective, 2011. e-Pub 2011.
111. You YN, Xing Y, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ, Cormier JN. Advanced-stage colon cancer prior to the screening age: Association with age, race, and insurance status J Clin Oncol 29(suppl; abstr 377), 2011. e-Pub 2011.
112. Ernst RD, Kaur H, You YN, Chang GJ, Rodriguez-Bigas M. Structured reporting for MRI staging of rectal cancer, 2010. e-Pub 2010.
113. You Y, Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Crane CH, Das P, Chang GJ. Multimodal salvage therapy for locally recurrent and re-recurrent rectal cancer, 2010. e-Pub 2010.
114. Chang GJ, Maru D, Agarwal A, Schlette E, Wolff R, Rodriguez-Bigas M, You N, Feig B, Kopetz S, Skibber J, Eng C. Histophathologic responses in primary tumors of patients with metastatic colorectal carcinoma after neoadjuvant systemic chemotherapy alone, 2010. e-Pub 2010.
115. You YN, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM. Prognostic value of pain and quality of life in patients with locally recurrent rectal cancer, 2010. e-Pub 2010.
116. McAuliffe PF, Gershenwald JE, Lee JE, Badgwell BD, Ballo MT, Cormier JN, Mansfield PF, Chang GJ, Zagars GK, Camp ER. Role of sentinel lymph node biopsy in anorectal melanoma, 2010. e-Pub 2010.
117. Bowles TL, Hu, C, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Cancers of the Colon and Rectum, 2010. e-Pub 2010.
118. Eng C, Sethi S, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Shen J, Zhu J, Ohinata A, Hamilton SR, Li D. Proteomic analysis of potential tumor markers in AJCC stage II and III colon cancer, 2009. e-Pub 2009.
119. Eng C, Chang GJ, Das P, Rodriguez-Bigas M, Skibber JM, Qiao W, Rosner GL, Ukegbu LT, Wolff RA, Crane CH. Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal, 2009. e-Pub 2009.
120. Overman MJ, Hu CY, Wolff RA, Chang GJ. Impact of lymph node evaluation on survival for small bowel adenocaricnoma (SBA): Analysis of the Surveillance, Epidemiology and End Results (SEER) database, 2009. e-Pub 2009.
121. Hu C, Xing Y, Cormier JN, Chang GJ. The validity of cause of death coding within the surveillance, epidemiology, and end results (SEER) registry, 2009. e-Pub 2009.
122. Fukami N, Skibber JM, Chang GJ. Salvage endoscopic antegrade dilation on tight or complete coloanal anastomotic stricture via ileostomy, 2009. e-Pub 2009.
123. Xing Y, Chang GJ, Hu C, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. Conditional survival estimates provide better prognostic information for melanoma survivors: result from the SEER dataset 1988-2000, 2009. e-Pub 2009.
124. Bedrosian I, Hu CY, Chang GJ. Contralateral prophylactic mastectomy and survival, 2008. e-Pub 2008.
125. Chang GJ, Hu C, Rodriguez-Bigas MA, Skibber JM. Improving colon cancer prognosis using index of metastasis: A SEER analysis, 2008. e-Pub 2008.
126. Chang GJ, Taylor SH, Rodriguez-Bigas MA, Eng C, Skibber JM. The twelve lymph node standard in colon cancer: Can it be achieved?, 2008. e-Pub 2008.
127. Bowles TL, Xing Y, Mungovan KS, Chang GJ, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Conditional survival estimates improve over 5 years for patients with node-positive melanoma, 2008. e-Pub 2008.
128. Chang GJ, Taylor SH, Rodriguez-Bigas MA, Eng C, Skibber JM. The twelve lymph node standard in colon cancer: Can it be achieved?, 2008. e-Pub 2008.
129. Chang GJ, Hu C, Eng C, Skibber JM, Rodriguez-Bigas MA. An epidemiologic study of conditional survival in colon cancer, 2008. e-Pub 2008.
130. Chang GJ, Hu C, Rodriguez-Bigas MA, Eng C, Skibber JM. Improving colon cancer prognosis using index of metastasis: A SEER analysis, 2008. e-Pub 2008.
131. Kesmodel SB, Ellis LM, Lin E, Chang GJ, Ebdalla EK, Kopetz ES, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not increase postoperative complications in patients undergoing hepatic surgery for colorectal cancer liver metastases, 2007. e-Pub 2007.
132. Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Predicting outcomes after surgery for locally recurrent rectal cancer, 2007. e-Pub 2007.
133. Chang GJ, Rodriguez-Bigas MA, Skibber JM. An epidemiologic study of N-stage after preoperative radiotherapy for rectal cancer, 2007. e-Pub 2007.
134. Badgwell B, Feig BW, Ross M, Mansfield PM, Chang GJ. Pneumoperitoneum in the cancer patient, 2007. e-Pub 2007.
135. Gray KD, Feng L, Skibber JM, Chang GJ, Rodriguez-Bigas MA. Ethnic disparities in colorectal cancer outcomes persist despite treatment at a comprehensive cancer center, 2007. e-Pub 2007.
136. Al-Refaie WB, Pisters PW, Chang GJ. Gastric adenocarcinoma in young patients: A population-based appraisal, 2007. e-Pub 2007.
137. Das P, Bhatia S, Eng C, Ajani, JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Krishnan S, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer, 2007. e-Pub 2007.
138. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Krishnan S, Janjan N, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer, 2007. e-Pub 2007.
139. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM. An epidemiologic study of N-stage and prognosis after preoperative radiotherapy for rectal cancer, 2007. e-Pub 2007.
140. Lim SJ, Feig BW, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Cleary K, Chang GJ. Evaluation of sentinel lymph node for staging accuracy in colon cancer, 2007. e-Pub 2007.
141. Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey N, Rodriguez-Bigas MA, Curley SA, Feig BW. Complication rates following hepatic surgery in patients receiving neoadjuvant bevacizumab (BC) for colorectal cancer (CRC) liver metastases, 2007. e-Pub 2007.
142. Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Surgical salvage with bone resection for locally recurrent rectal cancer, 2007. e-Pub 2007.
143. Al-Refaie WB, Pisters PW, Chang GJ. Proximal versus total gastrectomy for proximal gastric cancer, 2007. e-Pub 2007.
144. Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Composite sacral resection for recurrent rectal cancer, 2007. e-Pub 2007.
145. Zager JS, Gannon CJ, Chang GJ, Feig BW, Skibber J, Rodriguez-Bigas MA. Pelvic exenteration affords safe and durable treatment for locally advanced rectal adenocarcinoma (LARC), 2006. e-Pub 2006.
146. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas MA. Extending the limits for sphincter preservation for rectal cancer with margins less than or equal to 1cm, 2006. e-Pub 2006.
147. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Ra W, Eng C, Janjan NA, Krishnan S, Crane CH. Predictors of tumor responlse and downstaging in patients treated with preoperative chemoradiation for rectal cancer 66 (Suppl):S167-68, 2006. e-Pub 2006.
148. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas MA. Are we under-treating rectal cancer in elderly patients? A population based appraisal, 2006. e-Pub 2006.
149. Choi E, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Predicting outcome after aggresive surgical resection of locally recurrent rectal cancer, 2006. e-Pub 2006.
150. Chang GJ, Kattepogu KM, Wey J, Gannon C, Crane CH, Janjan N, Feig BW, Skibber JM, Rodriguez-Bigas MA. sphincter preservation in distal rectal cancer beyond the 2 cm rule, 2006. e-Pub 2006.
151. Das P, Bhatia Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Ellis LM, Lin EH, Janjan N, Crane C. Neoadjuvant chemoradiation with capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: a matched case-control study, 2005. e-Pub 2005.
152. Chang GJ, Liu T, Feng S, Bedolli M, O’Rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts, 2002. e-Pub 2002.
153. Hajjar MA, Posselt AM, Lang J, Szot GL, Chang GJ, Stock PG. Ad-CTLA4Ig but not Ad-CD40Ig prolongs allogeneic islet graft survival in a murine islet transplantation model. American Journal of Transplantation, 2002. e-Pub 2002.
154. Chang GJ, Adey D, Tomlanovich S, Amend W, Vincenti F. Early Histology, Acute Rejection, and Outcome in Renal Transplant Patients with Severe Delayed Graft Function Treated with a Calcineurin Inhibitor-Free Regimen 12:882A, 2001. e-Pub 2001.
155. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high grade anal squamous intraepithelial lesions—a prospective study, 2001. e-Pub 2001.
156. Chang GJ, Mahanty HD, Hajjar MA, Hirose R, Freise CE, Stock PG, Ascher NL, Roberts JP. ’Spanish Miracle’ VS. the U.S.-a difference in organ utilization?. American Journal of Transplantation 1(S1):219, 2001. e-Pub 2001.
157. Chang GJ, Mahanty HD, Quan D, Freise CE, Stock PG, Ascher NL, Roberts JP, Hirose R. Sirolimus immunosuppression for liver transplantation improves renal dysfunction. American Journal of Transplantation 1(S1):310, 2001. e-Pub 2001.
158. Mahanty H, Lou C, Chang GJ, Roberts JP, Baxter-Lowe LA. What are your chances of getting a zero antigen mismatched kidney?. American Journal of Transplantation 1/S1:170, 2001. e-Pub 2001.
159. Hajjar MA, Chang GJ, Mahanty HD, Stock PG, Hirose R, Freise CE. Superior rejection rates with thymoglobulin induction in simultaneous pancreas kidney transplantation. American Journal of Transplantation 1(S1):327, 2001. e-Pub 2001.
160. O’Rourke R, Lower JA, Chang GJ, Kang SM, Ascher NL, Roberts JP, Stock PG. Myoblasts engineered to express TGF-b-1 and Fas ligand co-transplanted with murine islet allografts do not prevent a neutrophilic infiltrate or prolong allograft survival. Transplantation 69(8):S243, 2000. e-Pub 2000.
161. Chang GJ, Melzer JS, Freise CE, Stock PG. The safety of simultaneous pancreas-kidney transplantation in the hepatitis C positive patient. Transplantation 69(8):S209, 2000. e-Pub 2000.
162. Chang GJ, Freise CE, Hirose R, Ascher NL, Roberts JP, Vincenti F, Stock PG. A new immunosuppressive era—transplantation without steroids, 2000. e-Pub 2000.
163. Chang GJ, Vincenti F, Robert JP, Stock PG, Hirose R. Sirolimus provides effective immunosupression in kidney transplant recipients with delayed or impaired graft function, 2000. e-Pub 2000.
164. Chang GJ, Mahanty HD, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of Sirolimus in Liver Transplantation—Use in patients for whom calcineurin inhibitors are contraindicated 32/(4:2/2):344A, 2000. e-Pub 2000.
165. Chang GJ, Ascher NL, Freise CE, Jaskula J, Mathias R, Portale A, Potter DE, Stock PG. Daclizumab provides superior immunosuppresion for pediatric renal transplants 67(9):S585, 1999. e-Pub 1999.
166. Chang GJ, O’Rourke R, Lee I, Stock PG, Vincenti F. One or Two Doses of Dacluzimab Provide Effective Immunosuppression for Renal Transplant Patients with High Immunologic Risk or with Delayed Graft Function 67(7):S149, 1999. e-Pub 1999.
167. Berber E, Engle KL, Chang GJ, Macho J, Pear JM. Selective use of tube cholecystostomy with interval laparoscopic cholecystectomy in acute cholecystitis, 1998. e-Pub 1998.
168. Chang GJ, Honda HM, Ignarro LJ, Demer LL. Nitrix oxide oxides low density lipoprotein in a pH-dependent manner, 1993. e-Pub 1993.
169. Moskowitz JB, Mork ME, Maghanoy E, Nguyen ST, Harrison DM, Lovero KR, Das P, Chang GJ, Thirumurthi S, Ricciardiello L, Sanchez EV, You Y. Empowering young-onset colorectal cancer patients with an accessible, self-navigable online platform for universal germline testing. 2025 ASCO Annual Meeting.
170. Basch E, Dueck AC, Mitchel SA, Mamon HJ, Rogak LJ, Ginos BF, Weiser MR, Saltz LB, Chang GJ, Minasian LM, Denicoff AM, Thanarajasingam G, Rubinson DA, Gordon VL, Goerge TJ, Farma JM, O'Reilly EM, Meyerhardt JA, Shi Q, Scrag D. PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048). 2023 ASCO Annual Meeting.
171. Bhutiani N, Johnson B, Kopetz S, White M, Willis J, Uppal A, Chang GJ. Immune Checkpoint Blockade Combined with Targeted Therapies Provide Increased Disease Control in Mismatch Repair-Proficient Colorectal Cancer with Peritoneal Metastases. ASCO Gastrointestinal Cancers Symposium.
172. Chang GJ, Childers CP, Hu CY. Impact of 2021 & 2023 Evaluation & Management (E&M) Code Updates on Surgical Oncologists. SSO 2024 Annual Meeting.
173. Konishi T, Uppal A, White M, Messick C, You YN, Skibber J, Bednarski BK, Chang GJ. Robotic Nerve-Preserving Lateral Lymph Node Dissection with Major Vessel Ligation - When and How We Do It?. 2024 American Society of Colon and Rectal Surgeons.
174. Ochiai K, Stanietzky N, Surabhi V, Ikeda A, Uppal A, White MG, Peacock O, Messick CA, Bednarski BK, You YN, Skibber JM, Kaur H, Chang GJ, Konishi T. Splenic enlargement after neoadjuvant chemotherapy predicts postoperative complications after curative proctectomy for rectal cancer. 2024 American Society of Colon and Rectal Surgeons.
175. Diggs LP, Galbraith NJ, Ramamurthy J, Bhutiani N, Hu ZI, Dasari A, Overman MJ, Kopetz S, Chang GJ, Bednarski BK, Trueba MG, Behman RS, Yin F, Ajami NJ, Wargo JA, Bullman S, Johnston CD, You Y, White M. A phase II trial utilizing metronidazole to optimize the microbiome of rectal adenocarcinoma undergoing neoadjuvant therapy. 2025 ASCO Annual Meeting.
176. Ochiai K, Bhutiani N, Uppal A, You Y, Bednarski BK, White M, Holliday E, Das P, Chang GJ, Konishi T. Long-course chemoradiation vs short-course radiation in total neoadjuvant therapy for rectal cancer: propensity score case-matched analysis. 2025 ASCO Gastrointestinal Cancers Symposium.
177. Miyakawa T, Lie JJ, Hu C, Ochiai K, Behman RS, Guraieb-Trueba M, Bednarski BK, Konishi T, Messick C, You Y, Holliday E, Noticewala SS, Das P, Kaur H, Rauch GM, Huey RW, Dasari A, Chang GJ. Survival outcomes in rectal cancer with ypTNM vs pTNM staging after neoadjuvant therapy. 2025 ASCO Annual Meeting.
178. Shi Q, Chang GJ, Pederson LD, Asare EA, Jin Z, Cohen R, Meyerhardt JA, Andre T, Tie J, Dixon JG, Palis BE, Ballman KV, Yothers G, Ma Z, Alberts SR, Shi C, Washington MK, Taieb J, Steele S, Goldberg RM. Proposed changes to the pathologic staging for colon cancer (CC): AJCC Colon Cancer Expert Panel (AJCCCCEP). 2025 ASCO Annual Meeting.

Book Chapters

1. Bednarski, BK, Chang, GJ. Exenterative Resections Involving Vascular and Pelvic Sidewall Structures, 110-119, 2021.
2. Malakorn, S, Sammour, T, Chang, GJ. Robotic pelvic exenteration, 259-273, 2019.
3. Chang GJ, Ninan T. Colorectal Cancer Survivorship Care. In: Handbook of Cancer Survivorship Care. Springer, 2018.
4. Loehrer AP, Chang GJ. Implications of the Affordable Care Act on Surgery and Cancer Care. In: Surg Oncol Clin N Am. 4, 603-614, 2018.
5. Karanjawala, BE, Chang, GJ. Management of anal cancer, 555-566, 2015.
6. Karanjawala BE, Chang GJ. Management of Anal Cancer. In: Pelvic Cancer Surgery: Modern Breakthroughs and Future Advances. Springer, 555-66, 2015.
7. Bailey CE, Chang GJ. Clinical Trials: Handling the Data. In: Success in Academic Surgery: Clinical Trials. 2014. Springer, 2014.
8. Park IJ, Chang GJ. Salvage Surgery for Recurrent/Persistent Anal Cancer". In: Anal Cancer, A Multidisciplinary Approach. Demos Medical, 2013.
9. Pineda, CE, Chang, GJ, Welton, ML. Surgery in the Immunocompromised Patient, 2262-2272, 2012.
10. Chang GJ. Surgical Mentoring: Building Tomorrow's Leaders. In: Diseases of the Colon & Rectum. Springer, 2012.
11. Chang GJ, Shelton A, Welton ML. Large Instestine. In: Current Surgical Therapy. Appleton, 2009.
12. Welton, ML, Shelton, A, Chang, GJ, Varma, MG. Colon, rectum, and anus, 1011-1110, 2008.
13. Welton ML, Shelton A, Chang GJ, Varma M. Colon, Rectum, and Anus. In: Surgery: Basic Science and Clinical Evidence. Springer-Verlag, 2008.
14. Chang GJ. Open and Laparoscopic Surgery for Colon Cancer. In: Advanced Therapy in Surgical Oncology. Decker Press, 2007.
15. Shelton A, Chang GJ, Welton ML. Small Intestine. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2006.
16. Chang GJ, Feig BW. Cancer of the Colon, Rectum, and Anus. In: The M.D. Anderson Surgical Oncology Handbook. W.B. Saunders. Lippincott Williams & Wilkins, 2006.
17. Chang GJ, Shelton A, Welton ML. Large Intestine. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2006.
18. Chang GJ, Welton ML. Surgery in the Immunocompromised Patient. In: Shackelford’s Surgery of the Alimentary Tract. W.B. Saunders, 2005.
19. Welton ML, Chang GJ. Anorectum. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2005.
20. Chang GJ, Shelton A, Schrock TR, Welton ML. Large Intestine. In: Current Surgical Diagnosis and Treatment. Appleton Lange, 2002.
21. Chang GJ, Welton ML. Surgery in the Immunocompromised Patient. In: Shackelford’s Surgery of the Alimentary Tract. W.B. Saunders, 2002.
22. Chang GJ, Welton ML. Other Abdominal Emergencies: Appendicitis, Diverticulitis, and Ischemic Bowel. In: Hospital Medicine. Lippincott Williams & Wilkins, 683-694, 2000.
23. Massarweh N, Chang GJ. Comparative Effectiveness Research. In: Success in Academic Surgery: Health Services Research.
24. deRosa N, Chang GJ. Locally advanced and recurrent rectal cancer. In: Scientific American Surgery.

Books (edited and written)

1. Hunt, KK, Katz, MH, Veeramachaneni, N, Grubbs, EG, Wang, TS, Kanf, JM, Fields, RC, Maithee, SK, Chang, GJ, Halverson, AL, Reddy, RM, Martin, LW, Francfsatti, AB. Operative standards for cancer surgery, 2018.
2. Hunt, KK, Katz, MH, Veeramachaneni, N, Grubbs, EG, Wang, TS, Kanf, JM, Fields, RC, Maithee, SK, Chang, GJ, Halverson, AL, Reddy, RM, Martin, LW, Francfsatti, AB. Operative standards for cancer surgery, 2018.
3. Chang, GJ. Rectal cancer, 2018.
4. Chang GJ. Rectal Cancer: Modern Approaches to Treatment. Springer Nature, 2018.
5. Chang GJ. Operative Standards for Cancer Surgery, 2018.
6. Chang GJ. Operative Standards for Cancer Surgery. Lippincott Williams & Wilkins, 2015.

Letters to the Editor

1. Childers CP, Hu CY, Swisher SG, Wong SL, Chang GJ. Estimated Financial Impact of 2021 Office-Visit Work Relative Unit Updates on Surgical Global Periods. JAMA Surg 159: 1087-1089, 2024.
2. Malakorn S, Chang GJ. The Authors Reply. Dis Colon Rectum 62: e30-e31, 2019.
3. Sandhu L, Chang GJ. Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer. Ann Surg Oncol 25: 4049-4050, 2018.
4. Massarweh NN, Hu CY, Rodriguez-Bigas MA, Chang GJ. Reply to N.H. Turner et al and L. Dziki et al. J Clin Oncol 33: 1412, 2015.
5. Maru DM, Agarwal AA, Hu CY, Chang GJ. Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?. Cancer 120: 1282, 2014.
6. Bedrosian, I, Hu, C, Chang, GJ. Response. Journal of the National Cancer Institute 102: 1372-1373, 2010.
7. Feig, BW, Kesmodel, SB, Ellis, LM, Chang, GJ, Rodriguez-Bigas, MA. In Reply. Journal of Clinical Oncology 27: 1918, 2009.